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Abstract 
As individuals age, substantial physiological changes occur.  Most notably there 
is a decrease in muscle mass known as sarcopenia and an increase in arterial stiffness.  
In order to attenuate declines in muscle mass, resistance training effectively improves 
both muscle size and strength of older individuals.  However, the effects of resistance 
training on the arterial system are less clear with studies noting increased, decreased, 
and no change in arterial stiffness after resistance training.  Purpose: The purpose of 
this study was to determine how aging affected arterial stiffness and other 
cardiovascular measure responses to a whole body resistance training session. 
Methods:  Thirty-six men were separated into three groups based on age (Young-aged, 
YG: 20-39 years; middle-aged, MG: 40-59 years; older-aged, OG: 60-75 years). A 
randomized controlled cross-over design was used.  During one condition, participants 
rested for 30 minutes and in the other condition, participants performed whole-body 
resistance exercise consisting of leg press, bench press, knee flexion, lat pulldown and 
knee extension (3 sets of 10 reps at 65% one-repetition maximum for each exercise).  
Blood pressure, augmentation pressure, augmentation index, peripheral pulse wave 
velocity, central pulse wave velocity, heart function, and forearm blood flow were 
measured before and after each condition. Change scores from pre to post time points 
were used for analysis. Two-way repeated measures ANOVA was used to determine 
differences between conditions (exercise vs. control) and groups (YG vs. MG vs. OG). 
Statistical significance was set at p≤0.05. Results: No differences were found between 
age groups for blood pressure responses.  When groups were combined, peripheral 
systolic blood pressure significantly increased after exercise when compared to the 
xiii 
control condition (6 ± 7 vs. 1 ± 6 mmHg, p=0.003).  Also, peripheral (-5 ± 6 vs. 2 ± 4 
mmHg, p<0.001) and central diastolic blood pressures (-4 ± 6 vs. 2 ± 4 mmHg, 
p<0.001) significantly decreased when compared to the control condition.  
Augmentation index significantly increased after exercise when compared to the control 
condition for the YG (11 ± 8 vs. 0 ± 7%, p<0.001) but not for the MG (-1 ± 8 vs. -1 ± 
5%, p=0.788) or OG (-3 ± 7 vs. 2 ± 4%, p=0.076).  However, no significant changes 
were found for central pulse wave velocity.  Heart function was also not altered 
substantially between age groups after exercise.  Conclusion:  It appears that some 
cardiovascular variables are affected more by aging than others after performing 
resistance exercise.  Most notably, augmentation index is significantly elevated after 
resistance exercise in younger individuals but not in middle-aged and older-aged 
individuals when compared to a control condition.  However, no significant increases 
were noted for central pulse wave velocity for any age group.  Therefore, moderate 
resistance training does not appear to result in acute prolonged increases in arterial 
stiffness in middle-aged and older-aged adults. 
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Chapter I: Introduction 
Aging influences every system in the body.  From the brain and muscles, to the 
heart, each organ is affected in some degree by aging. In particular, the cardiovascular 
system and the neuromuscular system change with increasing age.  In the 
cardiovascular system, age causes the arteries to become stiffer (82).  This stiffening 
can have a negative effect on the cardiovascular system as a whole, and increases the 
risk of developing hypertension, left ventricular hypertrophy, and heart disease (48, 49).  
This increased arterial stiffening can result from decreased elastin, increased collagen, 
hypertrophied smooth muscle or even increased sympathetic tone (47).   
With aging, not only is the cardiovascular system affected, but the 
neuromuscular system also experiences significant changes.  One of the most dramatic 
changes that can occur in the neuromuscular system is the age-related loss of muscle 
mass, known as sarcopenia.  This loss of muscle mass can begin as early as age 25 but 
muscle mass declines substantially after the age of 50 (52).  In addition to the loss of 
muscle cross-sectional area, a significant decrease in type II muscle fiber size and 
number are reported, with type I fibers not having as great a decrease in size (51).  
Besides the loss of muscle fibers, spinal motor neurons numbers also decrease with age 
(1).  The neuromuscular junction is affected such that a decrease in the number of 
synaptic vesicles and a greater distance from the axonal button to the motor end-plate 
are reported (1).   
With these changes in the neuromuscular system, a significant decrease in 
power, strength, and functional ability become evident (58).  However, many of these 
negative results can be counteracted, to a degree, through resistance exercise.  
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Resistance exercise can substantially increase muscular strength, power, and muscle 
size in older individuals (57).  However, the muscle protein synthesis response to 
resistance training that causes muscle hypertrophy in older adults is less clear.  Some 
studies find an attenuated muscle protein synthesis response in older adults (27, 33) 
while other studies reveal no differences in responses to resistance exercise in older 
adults when compared to younger adults (34, 92).  A potential way to provoke a greater 
increase in muscle protein synthesis in older adults may be to increase the volume of 
exercise performed by these individuals (46).    
Unfortunately, less is known about the consequences of resistance training on 
the cardiovascular system.   Cross-sectional studies report a greater increase in arterial 
stiffness in resistance-trained men (14, 42, 61).  In chronic resistance training studies 
equivocal findings are reported.  Some studies in younger men report a significant 
increase in arterial stiffness and decrease in arterial compliance (41, 62).  Other studies 
report no change, or even a decrease, in arterial stiffness (71, 75).  In older adults, 
resistance training does not seem to alter arterial function, and one study even reported 
a significant decrease in arterial stiffness after resistance training (16, 71).   
Because of the conflicting evidence from different chronic studies, it might be 
more important to understand the acute changes in the cardiovascular system following 
resistance exercise.  Most studies have only investigated the cardiovascular responses of 
an acute bout of resistance training in younger men.  Resistance training seems to 
significantly increase arterial stiffness or decrease arterial compliance by 30 minutes 
post-exercise, with levels returning to normal by 60 minutes (24).  The high stress 
placed on the cardiovascular system in younger subjects who have more compliant 
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arteries may result in acutely increased arterial stiffness, particularly in the proximal 
aorta.  However, older subjects with increased arterial stiffness due to aging may not 
have a significant increase in arterial stiffness after resistance exercise.  
To date, no studies have examined the acute responses to a resistance training 
bout over a wide span of ages.  This is an important question and may potentially shed 
light on whether the change in arterial stiffness after an acute bout of training will be 
different due to differences in the stiffness of arteries from the aging process itself.  
Also, a variety of exercise protocols can be used, but a resistance exercise protocol that 
would promote muscle and is commonly used by older individuals should be 
investigated. 
Purpose 
The purpose of this study was to determine the influence of age on arterial 
stiffness, augmentation pressure, augmentation index, central and peripheral blood 
pressure, stroke volume, ejection fraction, cardiac output and forearm blood flow after 
an acute bout of moderate resistance exercise (65% 1-RM, 5 exercises, 3 sets of 10 
repetitions).  
Research Question 
How does aging affect arterial stiffness, augmentation pressure, augmentation 
index, central and peripheral blood pressures, stroke volume, ejection fraction, cardiac 





What is the influence of muscle mass on arterial stiffness and does the amount 
of muscle mass influence how stiff the arteries become after an acute bout of resistance 
exercise?  
Hypothesis 
It was hypothesized that between the ages of 18-39 years a significant increase 
in cardiovascular measures would be found post-exercise. It was also hypothesized that 
after the age of 40 years, an attenuated response in cardiovascular measures would be 
observed compared to individuals younger than 40 years.  
Subquestion Hypothesis 
It was hypothesized that greater amounts of muscle mass would result in greater 
increases in arterial stiffness due to an increased load on the arterial system after an 
acute bout of resistance exercise but that arterial stiffness measures would be greater at 
rest for individuals with smaller muscle mass.   
Significance 
No previous studies have examined the effects of age on the cardiovascular 
system after an acute bout of resistance exercise. The results of this study demonstrate 
how varying levels of arterial stiffness, due to the aging process, affect the arterial 
response to an acute bout of resistance exercise.  Furthermore, this study determined the 
influence of muscle mass on arterial stiffness after an acute bout of resistance exercise.  
Assumptions 
1. It was assumed that participants were free of cardiovascular diseases and other 
neuromuscular diseases as reported by either the participant or their physician.  
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2. It was assumed that participants were fasted 3 hours prior to measurements, had 
not consumed caffeine, alcohol or anti-inflammatory medication 12 hours prior 
to measurements and had not exercised 24 hours prior to measurements.  
3. It was assumed that participants accurately reported their levels of physical 
activity. 
Delimitations 
1. The findings in this study only apply to healthy men between the ages of 18-75 
years old. 
2. The sample was recruited from the surrounding areas of Norman and Oklahoma 
City, Oklahoma.  
Limitations 
1. This is an acute study, so conclusions about the effects of aging on chronic 
adaptations to resistance training cannot be made. 
Operational Definitions 
Arterial compliance: A measure of the elasticity of the arteries that is reflected from 
the relationship between pressure and volume changes in the artery.  This is inversely 
related to arterial stiffness.   
Augmented pressure: A measure of the difference in pulse wave pressure from the 
first systolic peak and second systolic peak.  It represents the augmented pressure from 
the reflected pulse waveform.   
Augmentation index: The ratio of the augmented pressure to pulse pressure expressed 
as a percentage which represents the index of pulse wave reflection.   
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Pulse wave velocity (PWV): The speed (meters per second) at which the pulse wave 
travels along the artery is related to the stiffness of the artery.  The greater the PWV, the 
stiffer the artery is.  
Stroke Volume: The volume of blood ejected during left ventricular contraction. 
End-diastolic Volume: The volume of blood held in the left ventricle when the heart is 
relaxed.   
Ejection Fraction: The ratio of stroke volume to end-diastolic volume that represents 
the fraction of blood ejected from the left ventricle during systole.  
Cardiac Output: The volume of blood pumped by the heart during one minute.  
Sarcopenia: The age-related loss of muscle mass as measured by the ratio of 
appendicular lean tissue mass (kg) to height (kg/m
2
). Sarcopenia would be diagnosed if 
this ratio was greater than two standard deviations below the young adult mean. 
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Chapter II: Literature Review 
Cardiovascular Changes with Aging 
Over the course of a lifetime, many physiological changes naturally occur.  All 
systems in the body gradually lose their efficiency to perform their functions, but two 
systems that are particularly affected by aging are the cardiovascular system and 
neuromuscular system.  The cardiovascular system includes the heart, the blood vessels 
and the blood which carries needed nutrients and hormones throughout the body and 
also disposes of wastes.  The heart is the pump of this system and pushes blood through 
the arteries and eventually back to the heart through the veins.  The left and right 
ventricles contract and produce the needed pressure to overcome the pressure pushing 
back on the aortic and pulmonary semilunar valves.  Oxygenated blood is then sent to 
the rest of the body, and deoxygenated blood is sent to the lungs.  With aging both the 
heart and arteries decline in function.  Specifically, a 40-50% difference in central 
arterial stiffness or compliance is found between ages 25 and 75 years, but not as much 
stiffening occurs in the peripheral arteries (63, 83).  
Even healthy adults (20-91 years old) without known cardiovascular disease can 
have increased arterial stiffening (87).  For example, in a group of Chinese individuals, 
arterial stiffening significantly increased from 2 months to 94 years (11).  This 
increased stiffening is most likely due to a change in the arterial structural components.  
The structure of the arteries changes over time such that the arterial wall thickens and 
the elastic laminae thin and become damaged while connective tissue and collagen 
fibers increase (67).  Furthermore, with aging, a lower ratio of elastic to collagen, 
smooth muscle cell hypertrophy or increased smooth muscle tone result (10).  One way 
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to measure this arterial stiffening is through pulse wave velocity (PWV).  When the left 
ventricle contracts, a pressure waveform is sent along the arteries.  The speed at which 
this pressure waveform travels is affected negatively by the stiffness of the arteries. 
Pulse wave velocity is measured by dividing the distance between two measurement 
sites by the time it takes for a pressure waveform to travel that distance (10).  Arterial 
compliance is the inverse of arterial stiffening and represents the change in arterial 
diameter divided by change in pressure (68).   
 Not only are the arteries affected by aging but so is the heart.  A thickening of 
the left ventricle with increasing age has been noted possibly due to higher arterial 
stiffness, thus increasing the pressure against which the heart must pump (56).  Also, 
there is an increase in the filling time due to an increase in the duration of myocardial 
relaxation (74).  In addition, pacemaker cells in the SA node, AV node, bundle of His 
and  Purkinje fibers decrease over time (74).  With respect to cardiac function, there is 
an increase in left ventricular end-diastolic pressure, an increase in early diastolic 
filling, an increase in myocardial stiffness and a decrease in baroreceptor sensitivity 
(74).  Despite these changes, cardiac output is preserved at rest in older adults free of 
disease due to the Frank-Starling mechanism (74).   
Neuromuscular Changes with Aging 
Even as the cardiovascular system is changing with age, the neuromuscular 
system is also changing.  One of the most notable effects of aging on the neuromuscular 
system is the age-related loss of muscle mass, also known as sarcopenia.  Sarcopenia is 
defined by using the ratio of appendicular lean tissue mass (kg) to height (kg/m
2
) (13).  
If this ratio is greater than two standard deviations below the mean of younger adults, 
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then sarcopenia would be indicated (13).  This loss of muscle mass can begin as early as 
25 years of age, but a greater decline in muscle mass is found after the age of 50 (52).  
The prevalence of sarcopenia can increase from 5% of people aged 65 to as much as 
50% of people aged 85 and over (64).  Frontera et al. (31) followed participants from 
ages 65 to 77 and found an average of 14.7% loss of total thigh muscle cross-sectional 
area (CSA), a 16.1 % loss of quadriceps femoris CSA and a 14.9% decrease in leg 
flexor muscle CSA.  In a cross-sectional study by Lexell et al. (52), the researchers 
estimated that after age 50 there is a 1% loss in muscle CSA per year. 
Interestingly, not all muscles seem to be affected the same way by aging.  For 
example, one study found that a greater decline in muscle mass in the lower extremities 
when compared to the upper extremities (38).  In addition, one study of Japanese 
women noted a site-specific decline in anterior upper and mid-thigh muscle thickness 
but not in the posterior thigh muscle thickness (7).  This finding is supported by other 
studies showing similar declines in the anterior leg muscles but not posterior leg 
muscles (4, 32).  Thus, differences in the loss of muscle mass may be happening at 
different rates in different muscle groups.  
 When examining the effects of aging on muscle fibers, both type I and type II 
fibers are altered.  Specifically, type II fibers exhibit decreases in muscle fiber CSA and 
in total number (51).  However, type I fibers tend to not to change in muscle fiber CSA 
and type II fibers become type I fibers through axonal sprouting (1).  This results in a 
grouping of fibers types instead of the usual mosaic pattern of muscle fiber types.  
Despite changes in muscle fiber CSA and number, the intrinsic power of muscle fibers 
does not seem to decrease with age (76, 86).   
10 
 
 Part of the resulting loss in skeletal muscle fiber and size is due to a loss of 
spinal motor neurons which can be due to apoptosis, reduced IGF-1signaling, increased 
cytokine levels or cell oxidative stress (1).  A 50% reduction in spinal motor neurons 
was found when comparing 20-40 year old subjects to subjects over the age of 60 (85).   
 The overall result of a decrease in muscle CSA, muscle fibers, and decreased 
nervous system capability is the age-related loss of strength, which has been termed 
dynapenia (58).  It is well established that muscle strength declines with aging (25).  
Loss of strength ranges from 20%  to 40% by the seventh and eighth decades of life and 
can be greater than 50% in the ninth decade of life (25).  Despite the well-established 
fact that strength declines with age, the relationship of decreases in strength to losses in 
muscle mass remains a topic of interest.  For example, Delmonico et al. (23) designed 
an interesting study that looked at the relationship between declines in muscle strength 
and declines in muscle mass in 1678 men and women over a five-year period.  The 
average age of participants at the beginning of five years was 73 years.  Thigh muscle 
CSA was measured using CT scans at the midfemur and strength was assessed by using 
the average maximum isokinetic muscle torque of participants at 60 degrees/second.  
The researchers found that knee extensor torque in men decreased by 16% but they only 
had a decrease of 5% in total thigh muscle CSA and that in women knee extensor torque 
decreased by 14% and total thigh muscle CSA decreased by 3%.  In addition, 
researchers also reported a significant increase in intramuscular fat in both men and 
women over the five-year period.  Overall, strength declines with age, but this may not 
be solely related to declines in muscle mass, as the rate at which these two measures 
decrease is not the same.  
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 Besides muscle influencing some of the strength-related declines with aging, 
decreased muscle mass found with aging is reported to be associated with increased 
arterial stiffness.  Ochi et al. (69) examined the relationship between arterial stiffness 
(brachial-ankle) and thigh muscle CSA (CTscan) in 468 men and women. A significant 
inverse relationship was found with arterial stiffness and muscle CSA.  Another study 
followed 2,405 participants over 6 years to determine the rate of changes between 
arterial stiffening and loss in muscle mass.  At baseline levels, the researchers found an 
independent negative association between arterial stiffness and lean arm mass, lean leg 
mass, and skeletal muscle density in men while in women arterial stiffness was only 
negatively associated with sarcopenic index and leg lean mass (2).  Using multivariate 
regression, the authors also determined that the increase in arterial stiffness was related 
to increases in the sarcopenic index independent of age.  Other evidence supporting this 
finding includes a study by Loenneke et al. (54), which reported that thigh muscle CSA 
as measured by peripheral quantitative computed tomography was inversely correlated 
with increases in augmented pressure and augmentation index, two indirect markers of 
arterial stiffness.  From these studies, muscle mass seems to play a role in arterial 
stiffness but a causal relationship has yet to be established.  
Resistance Training Effects on Strength, Functional Ability, and Muscle Mass 
In order to combat sarcopenia, numerous interventions including nutritional 
supplements, resistance training, or pharmacological interventions have been tried.  One 
effective way to increase muscle mass and muscular strength is through resistance 
training.  Despite the effects of age, older adults can increase muscular strength, power, 
and functional ability through resistance exercise (57).  Important components of 
12 
 
resistance training that can be altered include the intensity, the frequency and the 
volume of training.  Different combinations of these components can produce varying 
results.  A meta-analysis by Steib et al. (80) found that training between 60-80% 1-RM 
produced the greatest strength gains in older adults but the adaptations in functional 
ability were not different between high, moderate, or low-intensity resistance training.  
Intriguingly, low-intensity resistance training (20-30% 1-RM) when combined with 
blood flow restriction produces significant increases in muscle mass and strength and 
can thus be employed in older populations who may not be able to perform high-
intensity training (55).   
One crucial outcome to examine related to whether resistance training is truly 
combating sarcopenia is to examine the muscle hypertrophy response to resistance 
training.  In order to increase muscle size, muscle protein synthesis must be greater than 
muscle protein degradation.  At basal levels, the muscle protein synthesis and muscle 
protein degradation do not seem to differ between older individuals and their younger 
counterparts (88).  However, the results to a bout of resistance exercise do seem to vary.  
Some studies find an attenuated muscle protein synthesis response in older adults (27, 
33), while other studies reveal no differences in responses to resistance exercise in older 
adults compared to younger adults (34, 92).  However, when compared to younger 
adults, older adults may need a larger volume stimulus to increase muscle protein 
synthesis.  Kumar et al. (46) determined that doubling the volume of resistance exercise 
from 3 sets of 14 repetitions to 6 sets of 14 repetitions (40% 1-RM) or from 3 sets of 8 
repetitions to 6 sets of 8 repetitions (75% 1-RM) significantly increased muscle protein 
synthesis responses in older men to levels that were similar to those of younger men.  
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Older adults seem to have some anabolic resistance to resistance training for muscle 
hypertrophy but a greater volume is potentially needed to overcome this change with 
aging.   
Resistance Training Effects on the Cardiovascular System 
Indeed, resistance training is a key component to counteract the effects of 
sarcopenia.  While resistance training may positively affect the neuromuscular system, 
its effects on the cardiovascular system need more investigation.  To date, cross-
sectional, chronic, and acute studies have been used to examine the effects of the 
resistance training on the cardiovascular system.  However, equivocal findings currently 
make it difficult to decipher the exact consequences of resistance training for the 
cardiovascular system.  The next few sections will discuss the findings of cross-
sectional, chronic and acute resistance exercise on the cardiovascular system, with an 
emphasis on different age responses.  
Cross-sectional Studies 
Some cross-sectional studies examining the relationship between resistance 
training and arterial health have pointed to the idea that resistance trained men have 
decreased arterial compliance and increased arterial stiffness. For example, one study 
investigated cardiovascular differences in 19 young men (~26 years old) who had 
resistance trained for a minimum of three times a week for at least 12 months (no 
aerobic training) and compared them to a sedentary group who had not participated in 
an exercise program during the past 12 months (14).  The researchers found that 
resistance trained men had significantly lower aortic compliance, higher β-stiffness 
index and carotid pulse pressure, higher peripheral PWV (femoral-dorsalis pedis 
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arteries) and a similar central PWV (carotid-femoral arteries) compared to the sedentary 
group.  When comparing left ventricular mass, the resistance-trained group had a larger 
mean mass, but this was no longer significant when normalized for body size.  
The finding that central PWV was not different compared to the sedentary group 
is surprising, as greater β-stiffness index and carotid pulse pressure, a measure of 
stiffness in the aortic arch, were found in the resistance-trained group.   The authors 
suggest that central PWV measurement does not include the proximal part of the aorta 
and this is why central arterial stiffness may not have been different between groups 
(14).  The results of this study indicated that resistance-trained men have decreased 
arterial function but no difference in left ventricular size or function when normalized 
for body weight. However, the exact amount of time that participants had been 
resistance training or the type of resistance training they performed was not reported so 
precise conclusions on the effects of resistance training cannot be made from this study.  
Interestingly, a similar finding was reported by Miyachi et al. (61) who 
examined both young and middle-aged men who were either sedentary (~27 vs. ~51 
years old) or resistance-trained (~29 vs. ~51 years old).  Sedentary men had not 
participated in a regular exercise program in the previous two years while resistance-
trained men (no regular aerobic exercise) had trained for more than two years. The 
average training periods of younger and middle-aged men were five and 21 years 
respectively.  The authors found that the age-related decline in arterial compliance was 
30% greater in the middle-aged resistance-trained men compared to their sedentary 
counterparts.  On the other hand, no difference in arterial compliance was reported in 
younger sedentary and resistance-trained men.  Arterial compliance was also inversely 
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correlated with the number of years of resistance training. In addition, the authors also 
noted that left ventricular hypertrophy mass and index were greater in resistance-trained 
men when compared to sedentary men for their respective age group.  
Another cross-sectional study sought to determine if resistance training impaired 
arterial endothelial function (42).  A cold pressor test was performed in resistance-
trained men ranging from the ages of 28-49 years.  Resistance-trained men had 
performed vigorous resistance training for greater than 10 years with no concurrent 
aerobic training performed.  Resistance trained men had significantly higher brachial 
and carotid blood pressures and carotid arterial compliance was significantly lower than 
the control group. Furthermore, β-stiffness index was significantly higher in the 
resistance-trained men but after adjusting for mean arterial pressure, the differences 
were no longer statistically significant.  The change in carotid arterial diameter during 
the cold pressor test did not differ significantly between groups, indicating that 
endothelial function was not impaired relative to sympathetic activity in resistance-
trained men.  Also, carotid artery diameter and intima-media thickness were not 
different between groups.  Therefore, the lower arterial compliance in resistance-trained 
men could not be explained by differences in endothelial function or carotid artery 
diameter.  Hence, any differences between the groups may more likely be due to 
changes in the elastic and collagen components.  
Chronic Studies 
Cross-sectional data limit our conclusions due to numerous uncontrolled factors.  
However, chronic resistance training enables researchers to investigate how the 
cardiovascular system will respond to multiple training sessions while controlling for 
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many other factors.  When investigating how resistance training chronically affects the 
cardiovascular system, varying results are reported.  Differences in the studies 
investigating this include the type of measurement devices (ultrasonography vs. 
applanation tonometry), resistance training protocols, age, gender and duration of 
training.  The number of weeks trained ranges from 4 weeks to 4 months.  Two studies 
that trained young men for 4 months with either moderate (50% 1-RM) or high intensity 
(80% 1-RM) whole body resistance training indicated that arterial stiffness was 
significantly elevated or that arterial compliance was significantly decreased (41, 62).  
One study by Cortez-copper et al. (22) observed that, after 11 weeks of resistance 
training using sets with low reps and high weight, central arterial stiffness significantly 
increased in young women but peripheral arterial stiffness did not.  Unfortunately, it 
cannot be concluded from this study that resistance training actually caused this 
increase because central arterial stiffness was significantly elevated in the control group 
to levels that were higher than in the resistance training group after 11 weeks.  Another 
study reported that central PWV increased from 11.0 m/s to 12.7 m/s (14.5%) and that 
peripheral PWV increased from 11.5 m/s to 12.5 m/s (8.7%) in pre-hypertensive women 
(~47 years) after 4 weeks of resistance training (20).  These studies suggest that arterial 
stiffness may increase in younger men and women and pre-hypertensive women who 
perform resistance training.  
 On other hand, multiple studies suggest that resistance training may not have a 
negative impact on the cardiovascular system.  Rakobowchuk et al. (75) had young men 
perform whole body resistance training and determined its effects on arterial 
compliance.  After 12 weeks of performing high-intensity resistance training (80% 1-
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RM), no significant changes were found in arterial compliance.  Casey et al. (15) came 
to similar conclusions when they found no significant changes in aortic pressure wave 
reflections or central and peripheral PWV in young men and women who performed 2 
sets of 8-12 repetitions to failure for 12 weeks.  Even when resistance training is 
performed by post-menopausal women for 18 weeks, no significant changes in arterial 
pressure wave reflections or augmentation index are found (16). 
Some studies even demonstrate a positive effect on the cardiovascular system 
from resistance training when performed at lighter intensities.  Okamoto et al. (71) 
reported that premenopausal women who exercised at home using body weight and 
hand-held weights for 10 weeks had decreases in arterial stiffness.  Unfortunately, no 
control group was included in this study.  However, Okamoto et al. (70) had young men 
and women perform moderate-intensity resistance exercise (50% 1-RM) and a reduction 
in peripheral PWV was reported when compared to a control group.  The many 
differences in exercise protocols, duration and age groups make it difficult to decipher 
exactly how resistance training affects the cardiovascular system, especially with 
respect to age.   
Acute Studies 
One way to potentially examine some of differences in the response of the 
cardiovascular system to resistance training especially with regards to age is to examine 
the acute response.  Surprisingly, however, almost all of the acute studies have used 
younger populations.  When examining arterial compliance following a resistance 
training bout of nine exercises, DeVan et al. (24) reported that young men and women 
(~27 years) had significantly decreased central arterial compliance at 30 minutes post 
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exercise but central arterial compliance returned to baseline levels by 60 minutes.   
Yoon et al. (93) also reported that after performing eight resistance exercises at 60%  1-
RM, central arterial stiffness in young men increased at 20 minutes but not 40 minutes.  
However, another study found that central arterial stiffness remained elevated at 60 
minutes in young men (19).  Differences in the results of these two studies may come 
from the differences in exercise protocols used.  DeVan et al. (24) had participants 
perform 1 warm up set of 8-12 repetitions at 50% 1-RM and then a second set at 75% 1-
RM to failure, Yoon et al. (93) had subjects exercise at 60% 1-RM for 2 sets of 15 
repetitions, and Collier et al. (19) had participants exercise for 3 sets at 100% of their 
10-RM.   
Another study of young men (~25 years) also reported that central arterial 
stiffness significantly increased from 4.8 to 5.8 m/s but  peripheral PWV did not 
significantly change (8.7 to 9.0 m/s) in young men who performed 8 resistance 
exercises (35).  Even when participants only perform upper body exercises, it has been 
noted that arterial stiffness may increase after an acute bout of exercise.  Fahs et al. (29) 
noted that young men who performed 4 sets of 5 reps at 80% 1-RM of bench press and 
4 sets of 10 reps at 70% 1-RM for biceps curl exhibited increases in central arterial 
stiffness and an increase in augmentation index 15 minutes post-exercise.   
Only one study, to the author’s knowledge, investigated cardiovascular response 
differences between young and middle-aged men after resistance exercise.  
Unfortunately, only blood pressure responses were recorded before and after resistance 
exercise.  At baseline, middle-aged men (~48 years) had significantly lower arterial 
compliance (0.11 vs. 0.17 mm
2
/mmHg) and significantly higher carotid β-stiffness 
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index (7.3 vs. 3.95 a.u.) and brachial-ankle PWV (1,291 vs. 1092 cm/s) compared to the 
young men.  The exercise protocol had subjects perform 3 sets (40, 60, 80% 1-RM) of 
10 repetitions.  After performing this exercise protocol, middle-aged men had an 
attenuated response in systolic blood pressure (SBP) and diastolic blood pressure (DBP) 
compared to young men.  Thus, it is quite possible that attenuation in arterial stiffness 
responses would be observed in middle-aged men compared to younger-aged men.  
 With regards to the acute experiments on how aging influences the 
cardiovascular response to resistance exercise, a paucity of research exists.  Therefore, a 
greater understanding of how age affects the cardiovascular and hemodynamic response 
to an acute bout of resistance training is needed and such studies would lead to 
advances in understanding how resistance exercise affects the cardiovascular system.   
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Chapter III: Methodology 
Participants 
Participants were recruited from men ranging in age from 18-75 years.  They 
were recruited from the Norman and Oklahoma City, Oklahoma areas.  Participants 
who were 45 years or older were required to have their physician approve their 
involvement prior to beginning the study.   
Inclusion Criteria 
1. Men ranging between the ages of 18-75 years.  
2. Recreationally active men.  
3. No known orthopedic disorders that would prevent participation in the exercise 
session.  
4. Body mass under the DXA weight limit (300 1bs). 
5. Free from pulmonary, cardiovascular or metabolic diseases (asthma, diabetes, 
heart, uncontrolled hypertension or COPD). 
6. Not hypertensive (SBP > 140 and/or DBP  > 90) – this was either naturally or 
under control with medication.  
Exclusion Criteria 
1. Men outside the age range of 18-75 years.  
2. Any pulmonary, cardiovascular or metabolic diseases (asthma, diabetes, heart or 
COPD) 
3. BMI ≥ 30 kg/m2. 
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4. Highly resistance trained (in a resistance training program lifting ≥ 3 times per 
week within the previous 6 months or competitively lifted during the previous 2 
years). 
5. Highly endurance trained (perform vigorous endurance exercise ≥ 5 times per 
week within the previous 6 months or competitively raced during the previous 2 
years). 
6. Body mass over the DXA weight limit (300 lbs).  
7. Taking anabolic steroids.  
8. Smokers. 
Experimental Design 
A randomized controlled cross-over design was used in this experiment.  
Participants were males and separated into three different groups according to their age.  
One group included participants ranging from the ages of 20-39 years, the second group 
40-59 years and the third group 60-75 years.  Participants 45 years and older needed 
their personal physician to fill out a medical questionnaire and recommend them to 
participate.   
During the first visit, participants were screened and filled out a physical activity 
readiness questionnaire (PAR-Q), health status questionnaire, protected health 
information (PHI) authorization release form, and consent form. Resting blood pressure 
and ankle brachial index were measured to screen for hypertension and peripheral 
vascular disease.  After those measurements, standing height and weight were 
measured.  Participants were then familiarized with the one-repetition maximum (1-
RM) procedures for the leg press, chest press, knee flexion, lat pull-down, and knee 
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extension by performing several repetitions at a light load and then slightly increasing 
the load so that participants felt how the weight would change during the 1-RM 
procedure.   
At the second visit, muscle thickness (biceps, triceps, quadriceps, and 
hamstrings) was measured and a whole body DEXA scan was performed.  Subjects 
were encouraged to come to the visit well-hydrated and hydration status was checked 
using a spectrometer (urine specific gravity values between 1.004-1.029).  Following 
these tests, 1-RM tests for the leg press, chest press, knee flexion, lat pull-down, and 
knee extension were performed.   
Visit three and four were randomized such that one visit was a control visit 
while the other visit was the exercise session. At least 3 days separated the third and 
fourth visits (35).  At the beginning of the third visit, muscle thickness was measured 
again.   
During the control condition (CON) participants lay supine on a medical table 
for 8-10 minutes. Subjects were at least three hours postprandial, had not exercised for 
24 hours, and had not consumed caffeine/alcohol at least 12 hours prior to testing.  
After resting for 8-10 minutes, cardiovascular measurements were taken, which 
included resting blood pressure, radial pulse wave analysis (augmentation pressure, 
augmentation index, and central blood pressure), radial-carotid (peripheral) and 
femoral-carotid (central) PWV, heart rate, stroke volume, cardiac output, ejection 
fraction and resting forearm blood flow.  After these measurements, participants sat in a 
chair for ~ 20 minutes. Following the control waiting period of ~20 minutes, 
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participants lay supine on a medical table for ~10 minutes and then all the previous 
cardiovascular measurements were taken again. 
For the exercise condition (EX), participants lay supine on a medical table for 8-
10 minutes.  Cardiovascular measurements were then taken, which included resting 
blood pressure, radial pulse wave analysis (augmentation pressure, augmentation index, 
and central blood pressure), peripheral and central PWV, heart rate, stroke volume, 
cardiac output, ejection fraction and resting forearm blood flow.  After these 
measurements, participants performed resistance exercise consisting of five exercises: 
leg press, chest press, knee flexion, lat pull-down, and knee extension in that order. 
ACSM recommendations were used for the exercise protocol such that three sets of 10 
repetitions were performed at ~65% of the participant’s 1-RM with 2-3 minutes of rest 
between sets.  After all the exercises were completed, participants lay supine on a 
medical table ~5 minutes and then all the previous cardiovascular measurements were 
taken. 
Standing Height and Weight 
Participants removed shoes and any hat. A stadiometer (Stadi-0-Meter®, Novel 
Products, Inc., Rockton, Illinois, USA) measured height to the nearest cm.  Participants 
placed feet together with heels, buttocks and upper back against the wall with back 
straight and in the middle of the stadiometer.  Participants looked straight ahead with 
chin at a 90 degree angle. Participants took a deep breath and exhaled.  Weight was 
measured on a digital scale (TANITA Digital Scale, model BWB-800A, Japan).  
Participants removed shoes and emptied pockets of any items.  The digital scale was 
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turned on and set to kg and participants stood on the scale with both feet, and weight 
measured to the nearest 0.1 kg.   
Cardiovascular Parameters 
 Before testing of cardiovascular parameters subjects did not consume any 
caffeine/alcohol in the previous 12 hours or exercise in the previous 24 hours and were 
at least 3 hours postprandial (35).  Subjects lay supine for a period of 8-10 minutes 
before testing.  All parameters for each participant were taken at similar times of the 
day.  
Brachial Blood Pressure (BP) 
An automatic blood pressure cuff (Omron Healthcare Inc, Vernon Hills, IL) was 
used to measure blood pressure.  A blood pressure cuff was placed around the right 
upper arm. Cuff size was determined by measuring arm circumference at the midpoint 
of the arm (midpoint between olecranon and acromion process).  An adult cuff was used 
for arm circumferences ranging from 22-32 cm and a large adult cuff was used for 
circumferences ranging from 32-42 cm.  Two blood pressure measurements, separated 
by 1 minute, were taken at rest and after exercise. If the two systolic blood pressures 
differed by more than 5 mmHg, then a third blood pressure measurement was taken.  
The average of the two most similar blood pressure measurements was used for 
analysis.   
Arterial Measurements 
Applanation tonometry (SphygmoCor, AtCor Medical, Sydney, Australia) and a 
high-fidelity strain-gauge transducer (Miller Instruments, Houston, TX, USA) were 
used to measure the radial arterial pressure pulse waveforms.  A generalized validated 
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transfer function (SphygmoCor, AtCor Medical, Sydney, Australia) derived central 
blood pressures from radial blood pressure waveforms.  Applanation tonometry and 
three ECG electrodes measured PWV.  A high-fidelity strain-gauge transducer was 
placed on the right common carotid artery and right femoral artery and the pressure 
waveform was measured at each location.  The distance (measured with a tape 
measurer) from the right common carotid artery to the suprasternal notch was subtracted 
from the distance from the suprasternal notch to the right femoral artery and used as the 
distance to calculate the PWV.  The time delay from the R-wave of the ECG and the 
foot of the pressure waveform of the femoral arterial segment was subtracted from the 
time delay from the R-wave of the ECG and the foot of the pressure waveform of the 
carotid arterial segment to determine the transit time.  The same procedure was also 
done with the radial and carotid arteries to determine the peripheral PWV.  Pulse wave 
velocity was calculated as the distance between arterial segments divided by the transit 
time. 
Heart rate was determined from the time between waveforms.  Augmentation 
pressure, a measure of how much the initial aortic wave is augmented by the reflected 
aortic pressure wave from the periphery, was determined using specialized software 
(SphygmoCor; AtCor Medical, Sydney, Australia).  The augmentation index was 
calculated by dividing the augmentation pressure by the aortic pulse pressure and was 
expressed as a percentage.  Both measures were corrected for heart rate and expressed 
relative to a heart rate of 75 bpm.   
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Forearm Blood Flow 
Forearm blood flow was measured using venous occlusion strain-gauge 
plethysmography (EC-6; Hokanson Bellevue, WA, USA).  Participants rested supine 
for 10 minutes.  The forearm was elevated 10-15 cm above heart level using a foam 
pad. A venous occlusion cuff was placed on the wrist (SC10) and an arterial occlusion 
cuff on upper arm (SC12).  The largest circumference of the forearm was measured and 
then a mercury-filled strain gauge that was 2 cm less than the largest circumference was 
placed around the forearm.  The venous occlusion cuff was inflated to 200 mmHg for 1 
minute, after which the E20 rapid cuff inflator (set to 50 mmHg) was inflated for 7 
seconds and deflated for 8 seconds.  Forearm blood flow was then normalized to mean 
arterial pressure (FBF/MAP*1000) (flow/mmHg) for forearm vascular conductance.  
Heart Measurements 
Heart measurements were taken using two-dimensional M-mode 
echocardiography ultrasound unit with a 3.5 MHz probe (Fukuda Denshi UF-750XT, 
Tokyo, Japan).  The subject lay supine on a medical table and rested for 10 minutes 
prior to baseline testing.  After 10 minutes, the heart was located using the parasternal 
long-axis view.  Three heart beats were measured and the average value from the three 
beats was reported.  At the end of the systole and diastole, left ventricular internal 
diameter was measured.  The Teicholz method was used to determine end systolic and 
end diastolic volumes [End-diastolic volume (ml) = (7 x (end diastolic 
diameter)
3
)/(2.4+end-diastolic diameter) x and end systolic volume (ml)=(7 x (end 
systolic diameter)
3
)/(2.4 + end-systolic diameter) (84)].  Stroke volume (SV) was 
calculated as EDV-ESV.  SV Index (SV_Index) was calculated by dividing SV by body 
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surface area (BSA).  Cardiac output was calculated by multiplying SV x heart rate.  
Cardiac output index (Q_Index) was calculated by dividing cardiac output by BSA. 
Body surface area (cm
2
) was estimated using the equation from Dubois and Dubois (28) 
[BSA=71.84 x Height (cm)^0.725 x Weight (kg)^0.425] and was then converted to m
2
 
for analysis.  Ejection fraction was calculated by dividing SV by end-diastolic volume x 
100.    
Ankle-Brachial Index 
Participants lay supine on a medical bed for 10 minutes prior to testing.  After 
10 minutes a blood pressure cuff was placed around the right arm.  A Doppler probe 
(Hokanson, Inc) was placed on the brachial artery, the blood pressure cuff was slowly 
inflated and the highest pressure at which blood flow was present was recorded.  A 
blood pressure cuff was then placed on the lower leg around the right ankle.  A Doppler 
probe was placed at the posterior tibial artery and the highest pressure at which blood 
flow was present was recorded.  Ankle pressure was then divided by the brachial 
pressure. If ankle-brachial index was less than 0.9, the participants were excluded from 
the study.  
Muscle Thickness 
Muscle thickness was measured using B-mode ultrasound imaging with a 5.0 
MHz probe (Fukuda Denshi UF-750XT, Tokyo, Japan).  Muscle thickness was 
measured at the triceps, biceps, quadriceps and hamstring muscle groups.  The triceps 
was located on the posterior side of the upper arm at 60% distal between the acromion 
process and lateral epicondyle while the biceps was located on the anterior side of the 
upper arm at 60% distal between the acromion process and lateral epicondyle (3).  
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Quadriceps and hamstring muscles were located on the anterior and posterior surface of 
the upper leg at the midpoint between the greater trochanter and lateral condyle of the 
femur (3).   Two measurements were taken at each site.  There was no significant 
difference using paired sample t-tests between the two measurements for each muscle 
site (p>0.05) and the two measurements were significantly correlated with each other 
for each muscle site (r>0.994), so the average of the two measurements was used for 
analysis.  Muscle thickness was determined as the distance between the adipose tissue-
muscle interface and muscle-bone interface from the ultrasound image.  The same 
testing sites were used for both days by marking the site with a permanent marker.  
Muscle thickness (MTH) ratios were calculated in the upper leg by dividing the 
quadriceps by the hamstrings MTH (Q:H MTH ratio) and in the upper arm by dividing 
the biceps by the triceps MTH (B:T MTH ratio).  
Strength 
One-repetition maximum standard procedures were used to assess participants’ 
muscular strength.  Each participant was familiarized with the 1-RM protocol and 
weight machines (Cybex® isotonic weight machines) on the first visit.  Participants 
performed 1-RM tests following standard 1-RM procedures (12).  For example, an 
estimated 50% of participant’s 1-RM was performed between 8-10 times.  Participants 
rested for 1 minute and then performed 3-5 repetitions at 60-80% of their 1-RM.  After 
a 1 minute rest, participants performed one repetition and continued this pattern until 
the maximum amount of weight was lifted one time.  Between maximal lifts, 
participants rested between 2-3 minutes.  Strength testing included leg press, chest 
press, knee flexion, lat pulldown, knee flexion in that order.  
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Muscle Quality Index 
Muscle quality index was determined using several criteria.  Using MTH, knee 
flexion strength was divided by hamstrings MTH, knee extension strength was divided 
by quadriceps MTH, and total leg strength (leg press plus knee extension plus knee 
flexion) was divided by total leg MTH (hamstring MTH plus quadriceps MTH).  Also, 
total leg strength (leg press plus knee extension plus knee flexion) was divided by leg 
lean tissue.  
Body Composition 
Dual Energy X-ray Absorptiometry (DXA, GE Medical Systems, Lunar 
Prodigy, encore 2010 software version 13.31.016) assessed total bone free lean body 
mass using a total body scan in all participants during the second visit.  The DXA 
machine was calibrated on each testing day prior to scanning participants, and the 
scanning procedures were standardized for all participants.  Participants dressed in light 
clothing with no attenuating materials (e.g., metal).  Participants were placed in a supine 
position and arms were placed close to the sides of the body within the 60 cm scanning 
area on the DXA table.  Velcro straps were placed around the knees and ankles to hold 
the legs together during the scans.  Hydration status was determined using a 
refractometer.  Subjects were considered hydrated if urine specific gravity was between 
1.004 to 1.029 (9).  The lab %CV for total bone free lean tissue body mass was 1.27%.   
Statistical Analysis 
Differences between age groups and conditions were measured using a two-way 
repeated measures ANOVA [2 conditions (EX vs. CON) x 3 groups (YG vs. MG vs. 
OG)].  The changes scores from pre to post for each condition were used in the analysis.  
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If a significant interaction term was found, simple effects analysis using one-way 
ANOVA and paired sample t-tests was used.  If a significant condition main effect was 
found, paired sample t-tests were used on the marginal means.  If a significant group 
main effect was found, independent t-tests using a Bonferroni correction were 
performed on the marginal means.  A one-way ANOVA determined differences 
between groups at baseline for all variables.  The average values for muscle thickness 
(visit 2 and 3) and resting cardiovascular measures (visit 3 and 4) were used to analyze 
baseline group differences.  If the F-ratio was significant, follow-up testing was 
performed using Tukey’s post hoc test if Levene’s test of homogeneity of variance was 
not significant.  A Dunnett C test was used for follow-up testing if Levene’s test of 
homogeneity of variance was violated.  Pearson r-correlations and partial correlations 
were used to determine if there was any association between changes in arterial stiffness 
and muscle mass and changes in arterial stiffness and exercise volume while controlling 
for age. Reliability of muscle thickness and cardiovascular parameters was determined 
by calculating intraclass correlation coefficient (ICC3,1), standard error of the mean 
(SEM) and minimal difference (MD) (90).  Statistical significance was set at p≤0.05. 





Chapter IV: Results and Discussion 
Results 
Participant Characteristics 
A total of 43 participants were enrolled at the beginning of the study; however, 
four of those participants did not meet final inclusion criteria due to a BMI ≥ 30 kg/m
2
 
or SBP ≥ 140 mmHg.  One participant never received medical clearance from his doctor 
and another one could not finish the exercise session due to some nausea and light 
headedness so they were excluded from the study.  Participants were divided into a 
young-aged group (YG, n=12, 26.5 ± 3.3 yrs), middle-aged group (MG, n=14, 49.4 ± 
5.2 yrs) and older-aged group (OG, n=10, 67.4 ± 6.3 yrs).  No significant differences 
were found between age groups for height (p=0.63), body mass (p=0.15) or body mass 
index (BMI, p=0.39) (Table 1).   
Participants self-reported that the average number of days that they performed 
aerobic training was 3 days per week (n=18; the other 18 participants did not report any 
significant aerobic training but considered themselves recreationally active) and that 
they performed structured resistance training 2 days per week (n=17; the other 19 
participants did not report any significant resistance training).   
Three participants reported taking cholesterol medication (n=3, Lipitor and 
Gemfibrozil), two in the OG and one in the MG.  Two participants reported taking 
hypertensive medication (Lisinopril and HCT2), one in the OG and the other in the MG.  
One subject in the YG was taking Adderall and one subject in the YG was taking 





Table 1. Participant Characteristics  
 YG (n=12) MG (n=14) OG (n=10) 
Age (yrs) 26.5 ± 3.3 49.4  ± 5.2 67.4  ± 6.3 
Height (m) 1.76  ± 0.06 1.78  ± 0.07 1.78 ± 0.07 
Weight (kg) 74.6  ± 7.5 81.7  ± 9.7 77.6  ± 10.0 
BMI (kg/m
2
) 24.3  ± 1.8 25.7  ± 2.7 24.8  ± 3.4 
Right Side ABI 1.1 ± 0.1* 1.2  ± 0.1 1.2  ± 0.1 
Left Side ABI 1.1 ± 0.1 1.2  ± 0.1 1.2  ± 0.1 
Data presented as mean ± SD; BMI=Body mass index; ABI=Ankle Brachial Index; *p≤0.05 from MG 
and OG  
 
Body Composition 
The age groups were similar in total body fat percentage (p=0.77), total fat 
(p=0.48), total lean tissue (p=0.18), total fat free tissue (p=0.19) and sarcopenia index 
(p=0.08) (Table 2).  A significant one-way ANOVA (p=0.049) was found for leg lean 
tissue (kg); however, follow-up analysis revealed no significant difference between age 
groups (YG vs. OG, p=0.84; YG vs MG, p=0.16; MG vs OG, p=0.57).  No significant 
differences were found between groups for arm lean tissue (p=0.19) or trunk lean tissue 
(p=0.32).  The number of individuals with a sarcopenia index below 7.26 was two in the 
YG, one in the MG and three in the OG. All participants were adequately hydrated prior 









Table 2. Body Composition  
 YG (n=12) MG (n=14) OG (n=10) 
Body Fat% 21.7 ± 6.1 23.6 ± 8.6 23.6 ± 7.7 
Total Fat Tissue (kg) 15.6 ± 5.0 19.0 ± 8.2 18.1 ± 7.8 
Total Lean Tissue (kg) 55.9 ± 5.9 59.6 ± 6.4 56.2 ± 3.7 
Total Fat Free Tissue (kg) 59.0 ± 6.1 62.9 ± 6.7 59.6 ± 3.7 
Arm Lean Tissue (kg)   6.7 ± 1.0   7.1 ± 0.9   6.5 ± 0.6 
Leg Lean Tissue (kg) 18.1 ± 1.8 19.6 ± 2.3 17.6 ± 1.8 
Trunk Lean Tissue (kg)  27.0 ± 3.2 28.7 ± 3.2 28.1 ± 1.6 
Sarcopenia Index (kg/m
2
)   8.0 ± 0.7   8.4 ± 0.7   7.7 ± 0.9 
Data presented as mean ± SD 
 
Muscle Thickness 
Table 3 and Figure 1 describe differences in MTH between groups.  The average 
of the two muscle thickness measurements from visits two and three was used for 
analysis.  Muscle thickness was significantly different between groups for the 
quadriceps (p=0.006), biceps (p=0.048), triceps (p=0.02), H:Q MTH ratio (p=0.03) and 
B:T MTH ratio (p=0.004).  However, hamstring MTH was not significantly different 
between groups (p<0.99).  Further post-hoc analysis revealed that quadriceps MTH was 
significantly greater in the YG compared to the OG (p=0.004) but no differences were 
found between the YG and MG (p=0.30) or MG vs. OG (p=0.09).  Biceps MTH was 
significantly lower in the YG compared to the MG (p=0.047) but not the OG (p=0.17), 
nor between the MG and OG (p=0.90).  Triceps MTH was significantly lower in the OG 
compared to the MG (p=0.02) but not the YG (p=0.09), nor between the YG and MG 
(p=0.84).  The Q:H MTH ratio was significantly lower in the OG compared to the YG 
(p=0.03) but not the MG (p=0.24), nor between the YG and MG (p=0.46).  The B:T 
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MTH ratio was significantly lower in the YG (p=0.004) and MG (p=0.02) compared to 
the OG but not between the YG and MG (p=0.70).   
The Intraclass Correlation Coefficient, (ICC3,1) for MTH measurements was 
0.95 for quadriceps MTH, 0.91 for hamstrings MTH, 0.94 for biceps MTH and 0.95 for 
triceps MTH.  The standard error of the measurement (SEM) was 0.15 cm for 
quadriceps MTH, 0.17 cm for hamstrings MTH, 0.11 cm for biceps MTH and 0.15 cm 
for triceps MTH.  The minimum difference (MD) needed to see real changes was 0.42 
cm for quadriceps MTH, 0.48 cm for hamstrings MTH, 0.30 cm for biceps MTH and 
0.40 cm for triceps MTH.   
Table 3. Muscle Thickness 
 YG (n=12) MG (n=14) OG (n=10) 
Quadriceps MTH (cm) 5.48 ± 0.56‡ 5.13 ± 0.56 4.59 ± 0.69* 
Hamstrings MTH (cm) 6.00 ± 0.68 5.97 ± 0.44 5.99 ± 0.70 
Biceps MTH (cm) 3.48 ± 0.30† 3.88 ± 0.50* 3.80 ± 0.34 
Triceps MTH (cm) 3.87 ± 0.52 4.00 ± 0.52‡ 3.31 ± 0.78† 
Q:H MTH Ratio 0.93 ± 0.19‡ 0.86 ± 0.08 0.77 ± 0.12* 
B:T MTH Ratio 0.91 ± 0.10‡ 0.98 ± 0.12‡ 1.22 ± 0.36*† 
Data presented as mean ± SD; MTH=Muscle Thickness; Q:H MTH Ratio=Quadriceps to Hamstrings 
MTH Ratio; B:T MTH Ratio=Biceps to Triceps MTH Ratio; YG = Young-aged group; MG = 






Figure 1. Muscle Thickness 
Data presented as mean ± SD; YG = Young-aged group; MG = middle-aged group; OG = Old-aged 
group; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG 
 
Strength, Training Volume, and Muscle Quality 
One-repetition maximum (1-RM) values are reported in Table 4 and depicted in 
Figure 2.  Leg press 1-RM was significantly greater in the YG compared to the OG 
(p=0.01) but not the MG (p=0.37), and the MG was not significantly different compared 
to the OG (p=0.17). For chest press 1-RM, the YG and MG had significantly greater 
values compared to the OG (p=0.02 and p=0.02) but no difference was found between 
the YG and MG (p=0.98).  The YG was also significantly stronger for the knee 
extension exercise compared to the OG (p<0.05) but no difference was found between 
the YG and MG or MG and OG.  No significant difference was found between age 
groups for strength for either knee flexion or lat pulldown.  The total exercise volume 
performed during the exercise session was significantly different between age groups 
































(p=0.003 and p=0.02) but no difference was found between the YG and MG (p=0.63).  
No significant differences were found between groups for knee flexion to hamstrings 
MTH (p=0.13), knee extension to quadriceps MTH ratio (p=0.08).  However, a 
significant ratio was found when combining leg press, knee extension and knee flexion 
strength to leg lean tissue (p<0.001) such that the YG was greater than the MG 
(p<0.001) and OG (p<0.001) but no differences were found between the MG and OG 
(p=0.45).  In addition, when comparing total lower body strength (leg press, knee 
extension and knee flexion) to quadriceps and hamstring MTH, the YG was 
significantly greater than the OG (p=0.03) but no differences were found between the 
YG and MG (p=0.86) or MG and OG (p=0.08).  Also, knee flexion to knee extension 
strength was significantly different among groups (p=0.03) such that the YG had a 
lower ratio compared to the OG (p=0.03) but no differences were found between YG 













Table 4. One-Repetition Maximum 
 YG (n=12) MG (n=14) OG (n=10) 
Leg Press (kg) 151.8 ± 19.8‡ 137.6 ± 31.9 117.6 ± 23.5* 
Chest Press (kg) 75.8 ± 16.5‡ 74.5 ± 16.3‡ 55.5 ± 15.2†* 
Knee Flexion (kg) 77.6 ± 9.7 76.3 ± 15.7 65.9 ± 8.5 
Lat Pulldown (kg) 71.5 ± 10.6 70.3 ± 10.4 61.7 ± 9.5 
Knee Extension (kg) 85.7 ± 8.9‡ 74.7 ± 17.7 60.5 ± 12.1* 




7554.1 ±  
1333.7†* 
Knee Flexion to Knee 
Extension Ratio 
(kg/kg) 
0.91 ± 0.14‡ 1.04 ± 0.21 1.11 ± 0.14* 
Knee Flexion to Ham 
MTH Ratio (kg/cm) 
13.14 ± 2.46 13.66 ± 4.22 11.07 ± 1.53 
Knee Extension to 
Quad MTH Ratio 
15.77 ±2.30 14.55 ± 3.04 13.21 ± 2.06 
Leg Strength (leg 
press, knee extension, 
knee flexion) to Leg 
Lean Tissue (kg/kg) 
17.51 ± 1.45†‡ 14.69 ± 1.79* 13.86 ± 1.60* 
Leg Strength (leg 
press, knee extension, 




27.45 ± 1.96‡ 26.65 ± 5.07 23.12 ± 3.49* 
Data presented as mean ± SD; YG = Young-aged group; MG = middle-aged group; OG = Old-aged 







Figure 2. One-Repetition Maximum 
Data presented as mean ± SD; YG = Young-aged group; MG = middle-aged group; OG = Old-aged 
group; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG 
 
Baseline Cardiovascular Comparisons 
When comparing pre-exercise and pre-control values using a paired samples t-
test, no significance differences were found for peripheral SBP (pSBP), peripheral DBP 
(pDBP), central SBP (cSBP), central DBP (cDBP), mean arterial pressure (MAP), 
augmented pressure adjusted for heart rate of 75 beats per minute (AP_75), 
augmentation index adjusted for a heart rate of 75 bpm (AIx_75), peripheral PWV 
(pPWV), central PWV (cPWV), forearm blood flow (FBF), forearm vascular 
conductance (FVC), heart rate (HR), stroke volume index (SV_Index), cardiac output 
index (Q_Index), or ejection fraction (EF) (all p>0.05) for either the YG, MG or OG. 
Therefore, the values from the two pre-conditions were averaged and a one-way 











































variable. No significant differences were found between groups at baseline for pSBP 
(p=0.57), pDBP (p=0.051), cDBP (p=0.059), MAP (0.066), pPWV (p=0.052), FBF 
(p=0.38), FVC (p=0.35), HR (p=0.78), SV_Index (p=0.29), Q_Index (p=0.70), and EF 
(p=0.058). A significant difference was found between groups for cSBP (p=0.02), AP 
(p<0.001), AIx (p<0.001), and cPWV (p<0.001). Data are presented in Table 5.  
Correlations between variables and age are found in Table 6 and graphical 
representations are found in Figures 3-17.   
Table 5. Cardiovascular Baseline Characteristics 
  
 YG MG OG 
pSBP (mmHg) 123 ± 9 121 ± 8 125 ± 11 
pDBP (mmHg) 71 ± 4 75 ± 7 78 ± 7 
cSBP (mmHg) 104 ±7‡ 110 ± 8 115 ± 12* 
cDBP (mmHg) 72 ± 4 76 ± 7 78 ± 7 
MAP (mmHg) 86 ± 5 91 ± 7 94 ± 9 
AP_75 (mmHg) -3.25 ± 2.71‡† 2.46 ± 2.17* 5.35 ± 4.60* 
AIx_75 (%) -10.25 ± 7.25‡† 7.69 ± 6.06* 14.85 ± 11.08* 
pPWV (m/s) 7.61 ± 0.61 7.52 ± 0.47 8.29 ± 1.19 
cPWV (m/s) 5.92 ± 0.6‡ 6.74 ± 3.31‡ 8.29 ± 1.13*† 
FBF (ml/min/100ml) 2.78 ± 0.86 3.31 ± 2.19 2.45 ± 0.70 
FVC (flow/mmHg) 32.40 ± 10.37 36.98 ± 26.11 26.17 ± 6.65 










 24.90 ± 3.73 26.50 ± 5.29 27.07 ± 9.24 
EF (%) 57.58 ± 2.84 61.28 ± 4.43 61.69 ± 5.55 
Data presented as mean ± SD; YG = Young-aged group; MG = middle-aged group; OG = Old-aged 
group; peripheral SBP (pSBP); peripheral DBP (pDBP); central SBP (cSBP); central DBP (cDBP); 
mean arterial pressure (MAP); augmented pressure adjusted for heart rate of 75 beats per minute 
(AP_75); augmentation index adjusted for a heart rate of 75 bpm (AIx_75); peripheral PWV (pPWV); 
central PWV (cPWV); forearm blood flow (FBF); forearm vascular conductance (FVC); heart rate 
(HR); stroke volume index (SV_Index); cardiac output index (Q_Index); or ejection fraction (EF); * 












pSBP (mmHg) 0.07 0.67 
pDBP (mmHg) 0.38 0.02 
cSBP (mmHg) 0.48 <0.01 
cDBP (mmHg) 0.37 0.03 
MAP (mmHg) 0.40 0.02 
AP_75 (mmHg) 0.79 <0.01 
AIx_75 (%) 0.81 <0.01 
pPWV (m/s) 0.18 0.31 
cPWV (m/s) 0.66 <0.01 
FBF (ml/min/100ml) -0.04 0.83 
FVC (flow/mmHg) -0.09 0.60 










 0.14 0.46 
EF (%) 0.39 0.03 
Peripheral SBP (pSBP); peripheral DBP (pDBP); central SBP (cSBP); central DBP (cDBP); mean 
arterial pressure (MAP); augmented pressure adjusted for heart rate of 75 beats per minute 
(AP_75); augmentation index adjusted for a heart rate of 75 bpm (AIx_75); peripheral PWV 
(pPWV); central PWV (cPWV); forearm blood flow (FBF); forearm vascular conductance (FVC); 
















Figure 3. pSBP and Age 
pSBP = peripheral systolic blood pressure; yrs = years 
 
 
Figure 4. pDBP and Age 
pDBP = peripheral diastolic blood pressure; yrs = years 






































Figure 5. cSBP and Age 
cSBP = central systolic blood pressure; yrs = years 
 
Figure 6. cDBP and Age 
cDBP = central diastolic blood pressure; yrs = years 
 







































Figure 7. MAP and Age 
MAP = mean arterial blood pressure; yrs = years 
 
 
Figure 8. AP_75 and Age 
AP_75 = augmented pressure adjusted to a heart rate of 75 bpm; yrs = years 
 











































Figure 9. AIx_75 and Age 
AIx_75 = augmentation index adjusted to a heart rate of 75 bpm; yrs = years 
 
 
Figure 10. pPWV and Age 
pPWV = peripheral pulse wave velocity; yrs = years 







































Figure 11. cPWV and Age 
cPWV = central pulse wave velocity; yrs = years 
 
 
Figure 12. FBF and Age 
FBF= forearm blood flow; yrs = years 














































Figure 13. FVC and Age 
FVC= forearm vascular conductance; yrs = years 
 
 
Figure 14. HR and Age 
HR= heart rate; yrs = years 






















































Figure 15. SV_Index and Age 
SV_Index= stroke volume index; yrs = years 
 
 
Figure 16. CO_Index and Age 
CO_Index= Cardiac output index; yrs = years 
 





















































Figure 17. EF and Age 
EF= ejection fraction; yrs = years 
 
Peripheral SBP 
The reliability of hemodynamic measures was calculated from pre-exercise and 
pre-control conditions.  The ICC for pSBP was 0.75, the SEM was 4.7 mmHg and MD 
12.9 mmHg. Data are presented in Table 7.   




 Pre Post ∆ Pre Post ∆ 
YG 
(n=12) 
124 ± 9 132 ± 13 8 ± 8 122 ± 10 120 ± 11 -2 ± 4 
MG 
(n=14) 
120 ± 8 125 ± 8 5 ± 5 121 ± 9 122 ± 9 1 ± 7 
OG 
(n=10) 
124 ± 12 130 ± 11 5 ± 6 125 ± 10 129 ± 16 4 ± 8 
Data presented as mean ± SD; Units are in mmHg; YG = Young-aged group; MG = middle-aged 
group; OG = Old-aged group; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤.05 from OG; # p≤0.05 
condition main effect; § p≤0.05 group main effect; ¥ p≤0.05 interaction effect. 
 
A two-way repeated measures analysis with the change scores from pre to post 
revealed no condition*group interaction (p=0.07). A significant condition main effect 




















was found (p=0.003), such that the exercise condition had significantly larger changes 
in pSBP compared to the control condition (6 ± 7 vs. 1 ± 6 mmHg) but there was no 
significant group main effect between groups (YG: 3 ± 8 vs. MG: 3 ± 8 mmHg vs. OG: 
5 ± 9 mmHg, p=0.63).   
Peripheral DBP 
The ICC3,1 for pDBP was 0.78, the SEM was 2.9 mmHg, and the MD was 8.2 
mmHg. Data are presented in Table 8. 




 Pre Post ∆ Pre Post ∆ 
YG 
(n=12) 
72 ± 5 67 ± 9 -5 ± 6 70 ± 5 72 ± 7 1 ± 5 
MG 
(n=14) 
75 ± 6 69 ± 6 -6 ± 5 75 ± 8 77 ± 8 1 ± 5 
OG 
(n=10) 
77 ± 7 74 ± 7 -3 ± 5 78 ± 8 81 ± 9 4 ± 3 
Data presented as mean ± SD; Units are in mmHg; YG = Young-aged group; MG = middle-aged 
group; OG = Old-aged group; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; # p≤0.05 
condition main effect; § p≤0.05 group main effect; ¥ p≤0.05 interaction effect. 
   
Performing a two-way repeated measures analysis with the change scores from 
pre to post, no condition*group interaction (p=0.97) was found. A significant condition 
main effect was found (p<0.001), such that the exercise condition had significantly 
larger changes in pDBP compared to the control condition (-5 ± 6 vs. 2 ± 4 mmHg).  No 
significant group main effect was found between groups (YG: -2 ± 5 vs. MG: -2 ± 5 
mmHg vs. OG: 0 ± 6 mmHg, p=0.18).   
Central SBP 
The ICC3,1 for cSBP was 0.82,  the SEM was 3.8 mmHg and the MD was 10.6 
mmHg.  Data are presented in Table 9. 
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Table 9. Central SBP 
 Exercise¥ Control 
 Pre Post ∆ Pre Post ∆ 
YG (n=12) 104 ± 7 107 ± 10 2 ± 7 103 ± 9 102 ± 9 -2 ± 4‡ 
MG 
(n=14) 
110 ± 7 108 ± 6 -2 ± 5 110 ± 10 110 ± 10 1 ± 6 
OG (n=10) 115 ± 13 113 ± 10 -2 ± 7 115 ± 11 121 ± 16 5 ± 7
*
 
Data presented as mean ± SD; Units are in mmHg; YG = Young-aged group; MG = middle-aged 
group; OG = Old-aged group; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; # p≤0.05 
condition main effect; § p≤0.05 group main effect; ¥ p≤0.05 interaction effect. 
   
 
Performing a two-way repeated measures analysis with the change scores from 
pre to post, a significant condition*group interaction (p=0.02) was found but both the 
condition main effect and group main effect were not significant (p=0.23, p=0.42). 
Follow-up analysis found no significant difference between the exercise and control 
conditions for the YG (2 ± 7 vs. -2 ± 4 mmHg, p=0.052), MG (-2 ± 5 vs. 1 ± 6 mmHg, 
p=0.16), and OG (-2 ± 7 vs. 5 ± 7 mmHg, p=0.13).  For the exercise condition, a one-
way ANOVA across group was not significant (p=0.18), but a significant one-way 
ANOVA across group for the control condition was found (p=0.04).  The YG had 
significantly lower cSBP than the OG group (p=0.03) but no significant differences 
were found between the YG vs. MG (p=0.54) or MG vs. OG (p=0.21).   
Central DBP 
The ICC3,1 for cDBP was 0.79,  the SEM was 3.6 mmHg and the MD was 9.9 





Table 10. Central DBP 
 Exercise
#
  Control  
 Pre Post ∆ Pre Post ∆ 
YG (n=12) 73 ± 5 69 ± 9 -4 ± 7 71 ± 9 72 ± 7 1 ± 5 
MG 
(n=14) 
76 ± 6 71 ± 6 -5 ± 5 76 ± 10 77 ± 8 1 ± 4 
OG (n=10) 78 ± 8 76 ± 7 -2 ± 6 78 ± 11 82 ± 9 4 ± 3 
Data presented as mean ± SD; Units are in mmHg; YG = Young-aged group; MG = middle-aged 
group; OG = Old-aged group; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; # p≤0.05 
condition main effect; § p≤0.05 group main effect; ¥ p≤0.05 interaction effect. 
   
 
Performing a two-way repeated measures analysis with the change scores from 
pre to post, no significant condition*group interaction (p=0.91) was found. A significant 
condition main effect was found (p<0.001) such that the exercise condition had 
significantly greater changes in cDBP compared to the control condition (-4 ± 6 vs. 2 ± 
4 mmHg) but no significant group main effect was found between groups (YG: -1 ± 5 
vs. MG: -2 ± 5 mmHg vs. OG: 1 ± 6 mmHg, p=0.12).  
MAP 
The ICC3,1 for MAP was 0.81, the SEM was 3.7 mmHg and the MD was 10.2 
mmHg. Data are presented in Table 11. 
Table 11. MAP 
 Exercise
#
  Control  
 Pre Post ∆ Pre Post ∆ 
YG (n=12) 87 ± 5   85 ± 10 -2 ± 7 86 ± 6 85 ± 8 0 ± 4 
MG (n=14) 91 ± 6 87 ± 6 -4 ± 4 91 ± 8 92 ± 8 1 ± 5 
OG (n=10)  94 ± 11 92 ± 8 -2 ± 7 94 ± 9   98 ± 12 4 ± 4 
Data presented as mean ± SD; Units are in mmHg; YG = Young-aged group; MG = middle-aged 
group; OG = Old-aged group; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; # p≤0.05 
condition main effect; § p≤0.05 group main effect; ¥ p≤0.05 interaction effect. 




Performing a two-way repeated measures analysis with the change scores from 
pre to post, no condition*group interaction (p=0.44) was found. A significant condition 
main effect was found (p=0.004) such that the exercise condition had significantly 
larger changes in MAP compared to the control condition (-3 ± 6 vs. 2 ± 5 mmHg) but 
no significant group main effect was found between groups (YG: -1 ± 6 vs. MG: -2 ± 5 
mmHg vs. OG: 1 ± 6 mmHg, p=0.13).  
AP and AIx (Adjusted for HR at 75 bpm) 
The ICC3,1 for AP was 0.88, the SEM was 1.67 mmHg and the MD was 4.62 
mmHg. Data are presented in Table 12. 
 
Table 12. Augmentation Pressure 
 Exercise¥§ Control 














































Data presented as mean ± SD; Units are in mmHg; YG = Young-aged group; MG = middle-aged 
group; OG = Old-aged group; # p≤0.05 condition main effect; § p≤0.05 group main effect; ¥ p≤0.05 
interaction effect; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; 
a 
p≤0.05 from control 
condition; 
b 
p≤0.05 from exercise condition. 
   
Performing a two-way repeated measures analysis with the change scores from 
pre to post, a significant condition*group interaction (p=0.005) and group main effect 
(p=0.02) were found but the condition main effect was not significant (p=0.32). Follow-
up analysis found a significant difference between the exercise and control condition for 
the YG (4 ± 3 vs. 0 ± 2 mmHg, p=0.01) but not the MG (0 ± 4 vs. 0 ± 2 mmHg, p=0.88) 
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or OG (-1 ± 3 vs. 1 ± 2 mmHg, p=0.22).  In the control condition, a one-way ANOVA 
across group was not significant (p=0.29), but a significant difference in augmentation 
pressure across groups in the exercise condition was found (p=0.003).  The YG had 
significantly greater augmentation pressure than the OG group (p=0.01) and MG 
(p=0.006) but no significant differences were found between the MG vs. OG (p=0.84).   
The ICC3,1 for AIx was 0.89, the SEM was 4.46 mmHg and the MD was 12.37 
mmHg. Data are presented in Table 13. 
 
Table 13. Augmentation Index 
 Exercise¥§ Control 


















































Data presented as mean ± SD; Units are in %; YG = Young-aged group; MG = middle-aged group; 
OG = Old-aged group; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; # p≤0.05 condition 
main effect; § p≤0.05 group main effect; ¥ p≤0.05 interaction effect. 
   
 
Performing a two-way repeated measures analysis with the change scores from 
pre to post, significant condition*group interaction (p<0.001) and group main effect 
(p=0.006) were found, but the condition main effect was not significant (p=0.20). 
Follow-up analysis found a significant difference between the exercise and control 
condition for the YG (11 ± 8 vs. 0 ± 7%, p<0.001) but not the MG (-1 ± 8 vs. -1 ± 5%, 
p=0.79) and OG (-3 ± 7 vs. 2 ± 4%, p=0.08).  In the control condition, a one-way 
ANOVA across groups was not significant (p=0.38), but a significant difference in AIx 
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across groups in the exercise condition was found (p<0.001).  The YG had a 
significantly larger AIx change than the OG group (p=0.001) and MG group (p<0.001) 
but no significant difference was found between the MG vs. OG (p=0.81). 
Peripheral PWV 
 Peripheral PWV from pre-exercise to pre-control time points yielded an ICC3,1 
of 0.31, a SEM of 0.81 m/s and a MD of 2.24 m/s.  No significant relationship was 
found between total bone free lean tissue and pPWV (r=0.006, p=0.97). Data are 
presented in Table 14.  




 Pre Post ∆ Pre Post ∆ 
YG (n=12) 7.8 ± 0.5 7.1 ± 0.7 -0.6 ± 0.7 7.5 ± 1.0 7.9 ± 1.3 0.4 ± 0.9 
MG (n=14) 7.5 ± 0.8 7.6 ± 1.3 0.1 ± 1.1 7.6 ± 0.7 8.0 ± 0.8 0.4 ± 1.0 
OG (n=10) 8.1 ± 1.5 8.2 ± 1.2 0.0 ± 1.2 8.4 ± 1.3 8.5 ± 0.6 0.1 ± 1.1 
Data presented as mean ± SD; Units are in m/s; YG = Young-aged group; MG = middle-aged group; 
OG = Old-aged group; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; # p≤0.05 
condition main effect; § p≤0.05 group main effect; ¥ p≤0.05 interaction effect. 
   
Performing a two-way repeated measures analysis with the change scores from 
pre to post, no significant condition*group interaction (p=0.13) was found. A significant 
condition main effect was found (p=0.03), such that the exercise condition had a 
significantly lower pPWV when compared to the control condition (-0.2 ± 1.0 vs. 0.3 ± 
1.0 m/s), but no significant group main effect was found between groups (YG: -0.1 ± 
1.3 vs. MG: 0.3 ± 1.2 vs. OG: 0.1 ± 1.5 m/s, p=0.52).  
When examining individual changes, the YG had 10 participants who had 
decreases in peripheral PWV and 2 who exhibited increased pPWV following the 
exercise condition (Figure 18).  In the control condition, 6 participants increased pPWV 
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and 6 participants decreased pPWV.  However, none of the individual changes 
exceeded the MD of 2.24 m/s. 
 
Figure 18. YG Peripheral PWV Individual Responses 
Data presented as post-pre values for exercise and control conditions; PWV = pulse wave velocity.  
 
The MG had 8 participants who had decreases in pPWV and 6 who increased 
pPWV following the exercise condition (Figure 19). In the control condition, 8 
participants increased pPWV and 6 participants decreased pPWV.  However, none of 










































Figure 19. MG Peripheral PWV Individual Responses 
Data presented as post-pre values for exercise and control conditions; PWV = pulse wave velocity.  
 
The OG had 6 subjects who had decreases in pPWV and 4 who increased pPWV 
following the exercise condition (Figure 20). In the control condition, 7 participants 
increased pPWV and 3 participants decreased pPWV.  Only 1individual exceeded the 










































Figure 20. OG Peripheral PWV Individual Responses 
Data presented as post-pre values for exercise and control conditions; PWV = pulse wave velocity.  
 
Central PWV 
Central PWV from pre-exercise to pre-control time points had an ICC3,1 of 0.86, 
SEM of 0.50 m/s and a MD of 1.40 m/s.  No significant relationship was found between 
cPWV and total bone free lean tissue mass (r=-0.06, p=0.75).  The total volume of work 
performed and changes in cPWV after exercise were not related before (r=0.10, p=0.56) 










































Table 15. Central PWV 
 Exercise Control 
 Pre Post ∆ Pre Post ∆ 
YG 
(n=12)* 










8.3 ± 1.5 8.3 ± 1.8 0.04 ± 0.85 8.3 ± 0.9 7.9 ± 1.3 
-0.45 ± 
0.99 
Data presented as mean ± SD; Units are in m/s; YG = Young-aged group; MG = middle-aged group; 
OG = Old-aged group; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; # p≤0.05 condition 
main effect; § p≤0.05 group main effect; ¥ p≤0.05 interaction effect. 
   
Performing a two-way repeated measures analysis with the change scores from 
pre to post, no condition*group interaction (p=0.81), condition main effect (p=0.054) or 
group main effect (p=0.10) were found. When examining individual changes, the YG 
had 8 participants who had increase in cPWV and 4 who decreased cPWV following the 
exercise condition (Figure 21). In the control condition, 4 participants increased cPWV 
and 8 participants decreased cPWV.  Only 2 people in the exercise condition exceeded 






Figure 21. YG Central PWV Individual Responses 
Data presented as post-pre values for exercise and control conditions; PWV = pulse wave velocity 
In the MG, 8 participants had an increase in cPWV and 6 had a decrease in 
cPWV following the exercise condition (Figure 22). In the control condition, 8 
participants increased cPWV and 6 participants decreased cPWV.  Only 2 people in the 





































Figure 22. MG Central PWV Individual Responses 
Data presented as post-pre values for exercise and control conditions; PWV = pulse wave velocity 
 
In the OG, 5 participants had an increase in cPWV and 5 had a decrease in 
cPWV following the exercise condition (Figure 23). In the control condition, 4 
participants increased cPWV and 6 participants decreased cPWV.  Only 2 people in the 









































Figure 23. OG Central PWV Individual Responses 
Data presented as post-pre values for exercise and control conditions; PWV = pulse wave velocity 
Heart Rate 
Heart rate from pre-exercise to pre-control time points had an ICC3,1 of 0.86, a 
SEM of 3 bpm and a MD of 10 bpm.  Data are presented in Table 16.  
Table 16. Heart Rate 
 Exercise¥§ Control 
 Pre Post ∆ Pre Post ∆ 
YG (n=12)    58 ± 9  86 ± 12  28 ± 13a†‡  56 ± 8  54 ± 7  -2 ± 4b  
MG (n=14)   54 ± 10  69 ± 14   15 ± 9a*   53 ± 11  50 ± 8  -4 ± 5b  
OG (n=10)    55 ± 9   70 ± 18   15 ± 12a*    54 ± 10    51 ± 10  -3 ± 1b  
Data presented as mean ± SD; Units are in mmHg; YG = Young-aged group; MG = middle-aged 
group; OG = Old-aged group; # p≤0.05 condition main effect; § p≤0.05 group main effect; ¥ p≤0.05 
interaction effect; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; 
a 
p≤0.05 from control 
condition; 
b 
p≤0.05 from exercise condition. 
   
 
Performing a two-way repeated measures analysis with the change scores from 
pre to post, a significant condition*group interaction (p=0.033) and group main effect 





































Follow-up analysis found a significant difference between the exercise and control 
condition for the YG (28 ± 13 vs.  -2 ± 4 bpm, p<0.001), the MG (15 ± 9 vs. -4 ± 5 
bpm, p<0.001), and OG (15 ± 12 vs. -3 ± 1 bpm, p=0.005).  In the control condition, a 
one-way ANOVA across group was not significant (p=0.36), but there was a significant 
one-way ANOVA across groups in the exercise condition (p=0.016).  Heart rate for the 
YG was significantly greater than the OG group (p=0.027) and MG group (p=0.047) but 
no significant difference was found between the MG vs. OG (p=0.99). 
 
Stroke Volume Index  
Stroke volume index from pre-exercise to pre-control time points had an ICC3,1 
of 0.67, a SEM of 5 ml/beat/m
2
 and a MD of 14 ml/beat/m
2
.  Data are presented in 
Table 17. 
Table 17. Stroke Volume Index 
 Exercise Control 
 Pre Post ∆ Pre Post ∆ 
YG (n=12) 45 ± 8 43 ± 6 -2 ± 7 44 ± 7 46 ± 6 3 ± 6 
MG (n=12) 48 ± 9 49 ± 9 1 ± 8 52 ± 9 51 ± 10 -1 ± 3 
OG (n=8) 49 ± 9 49 ± 14 0 ± 9 48 ± 14 48 ± 10 -1 ± 9 
Data presented as mean ± SD; Units are in (ml·beat-1)·m-2; YG = Young-aged group; MG = middle-
aged group; OG = Old-aged group; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; # 
p≤0.05 condition main effect; § p≤0.05 group main effect; ¥ p≤0.05 interaction effect. 
   
 Performing a two-way repeated measures analysis with the change scores from 
pre to post, no significant condition*group interaction (p=0.16), group main effect 




Cardiac Output Index 
Cardiac output index from pre-exercise to pre-control time points had an ICC3,1 
of 0.73, a SEM of 3.0 ml/min/m
2
 and a MD of 8.2 ml/min/m
2
.  Data are presented in 
Table 18. 




 Pre Post ∆ Pre Post ∆ 
YG (n=12) 2.6 ± 0.4 3.7 ± 0.8 1.1 ± 0.7 2.4 ± 0.5 2.5 ± 0.5 0.1 ± 0.4 
MG (n=12) 2.6 ± 0.6 3.3 ± 0.7 0.7 ± 0.5 2.7 ± 0.5 2.5 ± 0.6 -0.2 ± 0.2 
OG (n=8) 2.7 ± 0.8 3.5 ± 1.5 0.8 ± 0.9 2.7 ± 1.1 2.5 ± 0.9 -0.2 ± 0.5 
Data presented as mean ± SD; Units are in [(l·min-1)·m-2]; YG = Young-aged group; MG = middle-
aged group; OG = Old-aged group; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; # 
p≤0.05 condition main effect; § p≤0.05 group main effect; ¥ p≤0.05 interaction effect. 
 
Performing a two-way repeated measures analysis with the change scores from 
pre to post, a significant condition main effect (p<0.001) was found but the 
condition*group interaction (p=0.95) and group main effect (p=0.11) were not 
significant. Follow-up analysis found a significant difference between the exercise and 







Ejection fraction from pre-exercise to pre-control time points had an ICC3,1 of 







Table 19. Ejection Fraction 
 Exercise  Control  
 Pre Post ∆ Pre Post ∆ 
YG (n=12) 59 ± 3 60 ± 4 1 ± 3 57 ± 4 59 ± 3 3 ± 4 
MG (n=12) 60 ± 6 62 ± 7 2 ± 5 63 ± 5 63 ± 4 0 ± 5 
OG (n=8) 62 ± 7 64 ± 6 2 ± 5 62 ± 6 62 ± 7 1 ± 7 
Data presented as mean ± SD; Units are expressed as %; YG = Young-aged group; MG = middle-aged 
group; OG = Old-aged group; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; # p≤0.05 
condition main effect; § p≤0.05 group main effect; ¥ p≤0.05 interaction effect. 
   
Performing a two-way repeated measures analysis with the change scores from 
pre to post, no significant condition*group interaction (p=0.41), group main effect 
(p=0.88) or condition main effect (p=0.59) was found. 
Forearm Blood Flow (FBF)  
The ICC3,1 for FBF was 0.69, the SEM was 1.30 ml/min/100ml and the MD was 
3.61 ml/min/100ml.  Data are presented in Table 20.  
Table 20. Forearm Blood Flow 
 Exercise¥# Control 
 Pre Post ∆ Pre Post ∆ 
YG 
(n=12) 
   2.54 ± 
0.71 












   3.63 ± 
2.94 




  2.99 ± 
1.51 






   2.44 ± 
0.78 




  2.46 ± 
0.71 




Data presented as mean ± SD; Units are in ml/min/100ml; YG = Young-aged group; MG = 
middle-aged group; OG = Old-aged group; # p≤0.05 condition main effect; § p≤0.05 group main 
effect; ¥ p≤0.05 interaction effect; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; 
a 
p≤0.05 from control condition; 
b 
p≤0.05 from exercise condition. 
   
 
Performing a two-way repeated measures analysis with the change scores from 
pre to post, a significant condition*group interaction (p=0.026) and condition main 
effect (p<0.001) were found but the group main effect was not significant (p=0.25). 
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Follow-up analysis found a significant difference between the exercise and control 
condition for the YG (3.28 ± 0.97 vs. -3.42 ± 0.94, p<0.001), the MG (1.27 ± 1.87 vs. -
2.5 ± 1.88, p<0.001) and the OG (2.21 ± 1.68 vs. -2.59 ± 1.63, p=0.001).  In the control 
condition, a one-way ANOVA across groups was not significant (p=0.28), but a 
significant one-way ANOVA across groups in the exercise condition was found 
(p<0.01).  The YG had significantly greater FBF than the MG group (p=0.007) and but 
no significant differences were found between the MG vs. OG (p=0.33) and YG vs. OG 
(p=0.26). 
Forearm Vascular Conductance (FVC) 
The ICC3,1 for FVC was 0.69, the SEM was 13.03 and the MD was 36.12. Data 
are presented in Table 21. 
Table 21. Forearm Vascular Conductance 
 Exercise¥#§ Control 











































Data presented as mean ± SD; Units are in (ml/min/100ml)·mmHg-1; YG = Young-aged group; 
MG = middle-aged group; OG = Old-aged group; # p≤0.05 condition main effect; § p≤0.05 group 
main effect; ¥ p≤0.05 interaction effect; * p≤0.05 from YG; † p≤0.05 from MG; ‡ p≤0.05 from OG; 
a 
p≤0.05 from control condition; 
b 
p≤0.05 from exercise condition. 
   
 
Performing a two-way repeated measures analysis with the change scores from 
pre to post, a significant condition*group interaction (p=0.011), condition main effect 
(p<0.001) and group main effect were significant (p=0.048).  Follow-up analysis 
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revealed a significant difference between the exercise and control condition for the YG 
(40.20 ± 13.50 vs. -7.01 ± 12.50 (ml/min/100ml)mmHg
-1
, p<0.001), the MG (15.97 ± 
22.62 vs. -6.61 ± 12.47 (ml/min/100ml)mmHg
-1
, p=0.001) and the OG (24.41 ± 18.87 
vs. -4.71 ± 2.96 (ml/min/100ml)mmHg
-1
, p=0.001).  In the control condition, a one-way 
ANOVA across groups was not significant (p=0.87), but a one-way ANOVA across 
groups in the exercise condition was significant (p<0.01).  The YG had significantly 
greater FVC than the MG group (p=0.007) but no significant difference was found 
between the MG vs. OG (p=0.54) or YG vs. OG (p=0.14). 
Discussion 
Main Findings 
The following are the main findings from this study: 
1.) In recreationally active men, no significant differences in body composition 
measures were found between age groups using DXA; however, using 
ultrasound a significant difference in site-specific muscle loss for the anterior 
thigh was noted in the OG compared to the YG. 
2.) At rest, the OG had significantly higher central blood pressures compared to the 
YG, but after performing moderate resistance exercise, no significant 
differences were found between age groups in blood pressure responses for 
either central or peripheral blood pressures. 
3.) Augmentation pressure and augmentation index were significantly elevated after 
exercise when compared to the control condition only in the YG. 
67 
 
4.) Despite significantly lower central arterial stiffness at rest in the YG compared 
to the OG, no significant increases in central arterial stiffness after exercise were 
found in any group when compared to the control condition. 
5.) Heart function parameters were similar among all age groups at rest, but after 
exercise the YG exhibited a significantly greater increase in heart rate compared 
to the other age groups.  However, no significant changes in stroke volume after 
exercise were noted in any group.  Thus, there was a significant increase in 
cardiac output post-exercise among all groups that was due primarily to the 
increased heart rate post exercise.  
6.) Forearm blood flow/conductance was significantly elevated in all groups post 
exercise, but the YG had significantly greater increases compared to the MG.  
Site-Specific Muscle Loss 
With aging, a significant decline in muscle mass occurs particularly in the fifth 
decade of life (31, 38).  However, resistance training attenuates this decline in muscle 
mass (50).  Intriguingly, when examining fat-free mass, body fat% and total bone free 
lean body mass in this study, no significant differences were found between age groups.  
Part of the explanation may be that these men were recreationally active, so the declines 
in the older individuals may not have been as great as expected.  Also, the sample size 
may not have been sufficiently large enough to detect differences between the groups.  
Another explanation for these findings may be that some of the differences in 
skeletal muscle may not have been detected by whole body examination.  When 
examining site-specific differences among age groups, a significant difference was 
found for several muscle groups.  For example, the anterior thigh (quadriceps) was 
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significantly larger by 0.89 cm or 16% in the YG when compared to the OG. Triceps 
MTH was significantly lower by 0.69 cm or 17% in the OG when compared to the MG.  
When examining the anterior to posterior MTH ratios, a significantly lower Q:H MTH 
ratio was noted for the OG compared to the YG, which denotes a loss of quadriceps 
muscle compared to the hamstring muscle.  This is consistent with other literature.  For 
instance, one study found this same pattern of site-specific muscle loss in both Japanese 
and German men (5).  In addition, site-specific muscle loss in the lower body has been 
found to be more detectable than the total skeletal muscle mass loss (8). Furthermore, 
site-specific upper body muscle loss is not as prevalent or noticeable as lower body site-
specific muscle loss (6).   Our results in the upper body, however, did show a difference 
between the MG and OG with a greater loss of the triceps compared to the biceps 
muscle.  However, when examining individual differences, two participants in the OG 
had low triceps MTH and due to the small sample size may have had a great influence 
on the results.  Overall, it appears that site-specific MTH measures are noticeably 
different among age groups and thus could be another assessment tool to determine the 
severity of muscle loss and what muscle groups to target with exercise.  
Peripheral and Central Blood Pressures 
Systolic blood pressure is positively associated with age and the prevalence of 
isolated systolic hypertension (SBP ≥ 140 mmHg and DBP < 90 mmHg) accounts for 
approximately 87% of hypertension cases in older adults (30, 73).  One way to prevent 
and treat high blood pressure is through exercise.  Much of the work performed in this 
area has focused on aerobic exercise to lower blood pressure, but more research is 
starting to be done investigating how resistance training affects blood pressure.  A meta-
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analysis reported a significant decrease in SBP (3.5 mmHg) and DBP (3.2 mmHg) after 
chronic resistance training (21).  Acute changes in blood pressure following resistance 
exercise may lead to these chronic changes.  However, the acute changes in blood 
pressure following resistance training have varied.   A majority of studies have 
examined peripheral blood pressures responses while only a few have examined the 
central blood pressure responses to resistance exercise (24, 93).  In addition, a 
comparison between the age groups of the responses of peripheral and central blood 
pressures to an acute bout of resistance exercise is lacking in the literature.  Therefore, 
this study provides insight into the effect that age has on both peripheral and central 
blood pressure responses to an acute bout of resistance exercise. 
The results from this study revealed that pSBP increased significantly among all 
age groups without a significant difference between groups. These changes after 
exercise were greater than the control condition when averaging the groups together (6 
vs. 1 mmHg).  This significant increase post-exercise is in agreement with past studies.   
One study found that after young women performed six upper and lower body exercises 
at 60% 1-RM (3 sets of 10 repetitions), pSBP was significantly elevated but by 15 
minutes it was no longer significantly elevated; however, at an intensity of 80% of 1-
RM, pSBP was still significantly elevated 15 minutes post exercise (66).   Fahs et al. 
(29) also noted in young men a significant elevation in peripheral SBP from 123 to 133 
mmHg after high-intensity upper body exercise.  In contrast, several other studies did 
not find a significant increase in SBP after resistance exercise.  Hill et al. (37) found 
that, immediately after performing circuit resistance exercise for 4 exercises at 70% 1-
RM to failure, SBP dropped by over 22 mmHg but that it returned to baseline by 1 
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minute and did not change during the next 60 minutes of recovery.  Rezk et al. (77) also 
did not find a significant change in peripheral SBP from pre-values 15 minutes after 
high-intensity exercise.  When examining the peripheral DBP response, this study found 
a significant decrease post-exercise that was similar across all age groups. Other studies 
have also revealed a similar phenomenon (29, 37, 77).  
Besides investigating how age influenced brachial blood pressure responses, we 
investigated the response of central blood pressure.  This is an important variable to 
consider, as central blood pressure may better reflect the load on the heart and also 
correlates with vascular disease and cardiovascular mortality to a greater extent than 
brachial blood pressures (78, 89).  In the current study, cSBP was not elevated after 
exercise despite a significant elevation in pSBP.  In addition, no differences were found 
between age groups.  This finding was somewhat surprising as a previous study found 
the opposite results.  DeVan et al. (24) found that pSBP did not change in young men 
and women after resistance exercise but cSBP significantly increased immediately after 
exercise and remained elevated until 30 minutes post exercise.  Another study, however, 
found no significant change in either peripheral or central blood pressures after 
resistance exercise (93).  The different findings between these studies could be, in part, 
due to differences in exercise intensities (60% 1-RM vs. 75% 1-RM) and sets and reps 
(2 sets of 15 reps for 8 exercises vs. 1 set to exhaustion for nine exercises).  Potentially 
performing exercises to exhaustion versus a certain number of repetitions could have 
influenced the response.  In our study, the load was a performed at 65% 1-RM, with a 
target number of repetitions that may not have been great enough to increase the cSBP.    
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Little is known about how age may influence the acute blood pressure response 
to resistance exercise.  In the current study, no significant difference was found in 
peripheral or central SBP and DBP among the different age groups.  This was contrary 
to our original hypothesis, suggesting that the OG would have a blunted response.  
Other literature suggests that a blunted response in blood pressure after resistance 
exercise would be found.  Kawano et al. (40) found a significant attenuation in the rise 
of SBP during resistance exercise for older subjects when compared to younger adults 
at the same relative intensity.  In addition, this same blunted response was found for 
SBP when the same absolute intensity was used for each group.  A reason for the 
discrepancy with the current study may be the measurement time points.  For instance, 
in the study by Kawano et al. (40), the researchers used the peak blood pressure 
response post-exercise to determine the differences in pressure changes among groups 
and found that by 60 seconds both SBP and DBP had returned to baseline levels.  
However, in the current study, blood pressure responses were measured at 5 minutes 
post exercise.  Therefore, a greater difference between age groups might have been 
noted if blood pressure was measured during or immediately after exercise.   
Overall, it appears that during resistance exercise recovery, there may be a range 
of SBP responses that can occur depending on when the measurement is taken and the 
type of exercises performed.  Considering that numerous variables can be manipulated 
to produce various strength and muscular adaptations, it is not surprising that different 
studies using various resistance training protocols have produced various cardiovascular 
responses.  This study was unique in that it investigated how individuals of varying age 
from 20-75 years respond to the same relative resistance training session.  Little 
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differences are noted in the blood pressure response to exercise for these different age 
groups when performing both lower and upper body exercise at 65% 1-RM for 3 sets of 
10 reps.   
Arterial Stiffness 
 One of the main goals of this study was to determine how aging affected arterial 
stiffness after performing a resistance training session.  The stiffness of the arteries is 
indirectly measured through examining augmentation pressure (AP) and augmentation 
index (AIx).  During resting conditions, AP and AIx were significantly greater in the 
MG and OG when compared to the YG. Interestingly, we found that, after performing a 
moderate resistance exercise session, both of these indices were significantly increased 
only in the YG and not the MG or OG.  This supports our original hypothesis that a 
greater amount of arterial stiffness would occur only in the YG and not the MG and 
OG.  The majority of previous research has only examined the young adult population’s 
arterial responses and reported a similar finding.  For instance, Fahs et al. (29) had 
young men perform high-intensity upper body resistance exercise and found that AIx 
increased from -8% to 11%.  Yoon et al. (93) also found that AIx significantly increased 
from -14% to -0.3% 20 minutes after exercise.  One study did find that AIx was not 
changed in middle-aged women 20-25 minutes after performing leg press exercise (44), 
although in overweight middle-aged women AIx increased post-exercise (43).  These 
results suggest that young adults may have greater acute changes in AIx post-resistance 
exercise than middle-aged and older adults.  
 One of the more common techniques for measuring arterial stiffness is through 
measuring PWV.  The greater the PWV, the stiffer the arteries are. In the current study, 
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the OG had significantly higher cPWV at rest when compared to the YG and MG.  
However, no significant changes in cPWV occurred for any group when the resistance 
training session was compared to the control session.  This is contrary to our original 
hypothesis and past research.  Typically, a majority of the literature investigating the 
acute changes in arterial stiffness in young adults reports significant increases post-
exercise.  One of the first studies to examine this issue found that young adults who 
performed resistance exercise to failure (75% 1-RM) had significantly decreased arterial 
compliance and increased β-stiffness index 5-10 minutes and 30 minutes after exercise 
(24).  Supporting this, Heffernan et al. (35) found that cPWV increased from 4.8 to 5.8 
m/s.  In our study, the YG had a much higher starting cPWV compared to the study by 
Heffernan et al. (35) (6.0 vs. 4.8 m/s) and this may partially explain why significant 
increases did not occur in our YG.  In addition, Yoon et al. (93) found that young men 
had a significant increase in cPWV 20 minutes after performing 8 exercises at 60% 1-
RM (2 sets of 15 reps).  
In the current study, it was found that cPWV changed by 0.5 m/s, 0.3 m/s and 
0.0 m/s for the YG, MG and OG respectively, but none of these changes reached 
statistical significance when compared to the control condition.  Interestingly, Collier et 
al. (19) found an increase in cPWV at 40 and 60 minutes post exercise in young adults 
but those changes were smaller compared to the current study (0.29 m/s vs. 0.5 m/s) and 
no control group was included in their study.  Differences in the amount of change in 
arterial stiffness could partly be due to intensity or the total training volume performed.  
When a low-intensity resistance upper body exercise was performed, carotid 
compliance increased and β-stiffness index decreased at 30 and 60 minutes post 
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exercise in young adults (72). Therefore, higher intensity exercise may provoke greater 
acute increases in arterial stiffness than lower intensities.  However, this may not be the 
entire explanation, as one study found that when only one leg performed high-intensity 
resistance exercise (85% 1-RM), no significant change was found in cPWV but a 
significant decrease in pPWV occurred (36). One other factor to consider is the volume 
of exercise performed.  In the current study, the YG and MG performed a significantly 
greater volume of work compared to the OG but volume was not correlated with 
changes in cPWV.  The current literature does not allow a clear conclusion on how 
training volume and intensities acutely affect arterial stiffness.  Studies investigating 
multiple bouts of different intensities or volume of exercise are needed to clarify how 
each of these factors could influence the acute effects of resistance training on arterial 
stiffness and what the long-term consequences may be.   
Both AIx and cPWV were not significantly elevated after resistance exercise for 
either the MG or OG.  This appears to be in line with findings from chronic studies.  In 
a meta-analysis, 2 of the 3 training studies measuring arterial stiffness in middle to old-
aged adults found no significant change in cPWV after resistance training (60).  
Multiple physiological changes happen with aging that may partially explain why little 
response in arterial stiffness is found after resistance training.  With aging, there is an 
increase in arterial stiffness from increased collagen, increased smooth muscle 
thickness, and increased vascular tone (10, 67).  In addition, there is higher sympathetic 
activity at rest in older individuals but these individuals have a blunted sympathetic 
response to exercise (65).  These various changes with aging would make it less likely 
for older individuals to experience significant increases in arterial stiffness following a 
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bout of resistance exercise.  Part of the reason differences were not found among the 
age groups for cPWV may be the larger than expected variation within each age group.  
Another reason for the lack of difference may be that cPWV could have a diurnal 
pattern.  The participants performed each of their respective visits at the same time of 
day; however, visits varied from the mornings to the afternoons for different 
participants.  It is unlikely that this had a large effect on the results, as cPWV has been 
shown to not exhibit significant diurnal variation (53). 
Peripheral PWV was another variable measured to determine how the peripheral 
vasculature responded to a resistance training session and if age influenced the 
response.  At rest, no significant differences were found among the YG, MG and OG 
for pPWV.  Also, no significant differences among age groups were found for changes 
in pPWV after exercise, but a significant decrease in pPWV was found after exercise 
when compared to the control condition (-0.2 ± 1.0 vs. 0.3 ± 1.0 m/s).  Some studies 
have reported no significant changes in pPWV, while others have reported a significant 
decrease.  Two studies compared resistance exercise to aerobic exercise and found that 
peripheral PWV was not changed after resistance exercise 20-40 minutes post exercise 
(19, 35).  Interestingly, when only one leg performed resistance exercise, a significant 
decrease in pPWV was found at 5 minutes and 25 minutes, with pPWV decreasing from 
8.7 to 7.5 m/s at 5 minutes post-exercise (36). The authors suggested that this decrease 
could be due to local factors released from the exercising muscle such as nitric oxide 
(NO), which improves arterial distensibility (91). However, other local factors may be 
involved because when NO production is blocked by a nitric oxide synthase blocker, a 
decrease in peripheral arterial stiffness is still found after aerobic exercise (81).   In the 
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current study, the declines in pPWV were relatively small (-0.2 m/s) and may have been 
due to a whole body exercise routine producing larger amounts of sympathetic 
activation than a single leg resistance session.   
Heart Rate, Stroke Volume, Cardiac Output and Ejection Fraction 
 Heart rate, stroke volume, cardiac output and ejection fraction are all important 
physiological measures of heart function.  In this study, heart rate increased 
significantly among all age groups but the greatest increase in heart rate was found in 
the YG.  No significant changes in stroke volume or ejection fraction were found after 
resistance exercise for any group.  There was a significant increase in cardiac output 
among all groups, but no difference was found between groups.  The increase in cardiac 
output could be contributed to the increased heart rate found in all groups.  These 
findings are similar to other studies examining heart rate and function after resistance 
exercise.  Heart rate has consistently been found to be elevated by 16-20 bpm after 
resistance training (24, 29, 93) but returns back to baseline levels by 60 minutes (24).  
When measuring cardiac output and stroke volume in young adults, Rezk et al. (77) 
noted a decrease in cardiac output after both low and high-intensity resistance exercise 
that the authors attributed to a decrease in stroke volume. In another study by Rossow et 
al. (79), no significant changes in cardiac output or stroke volume were found 30 
minutes after exercise. In the current study, a significant decline was not found for 
stroke volume; rather, cardiac output increased.  The significantly larger increases in 
heart rate in the YG compared to the MG and OG could be explained by a decrease in 
the responsiveness of the heart to sympathetic stimulation in older adults (18).  Overall, 
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the heart function is not greatly affected by age after resistance exercise, but a greater 
responsiveness in heart rate is found in younger individuals.   
Forearm Blood Flow and Forearm Vascular Conductance 
Finally, a significant increase in forearm blood flow and vascular conductance 
post-exercise was found for all age groups.  However, the YG had significantly greater 
increases in forearm blood flow and vascular conductance when compared to the MG 
but not the OG.  The increase in forearm blood flow after resistance exercise is quite 
common in the literature.  Collier et al. (19) found that, 40 minutes after resistance 
exercise, calf blood flow and forearm blood flow significantly increased.  Fahs et al. 
(29) also found that forearm blood flow increased after resistance exercise.  
Furthermore, middle-aged women also significantly increase forearm blood after 
resistance exercise (44).  The increase in forearm blood flow found among all the 
groups in this study may be due to increased vasodilators produced from the exercising 
limb.  Transient increases in sheer stress with resistance exercise could release NO and 
lead to the release of prostaglandins, endothelial derived hyperpolarizing factors, and 
acetylcholine that could increase local blood flow (45, 59).  It is unclear why in this 
study the YG and OG had similar responses while the MG was less responsive than 
these other groups.  This result is most likely due to the high resting forearm blood flow 
values in the MG compared to the YG and OG (3.63 vs. 2.54 and 2.44 ml/min/100ml). 
The high starting value in the MG could have caused a smaller response to be found in 
this group.   
It was hypothesized that the OG would also have decreased responses to 
exercise in forearm blood flow, but this was not the case.  Evidence both contradicts 
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and supports our finding.  For instance, Casey et al. (17) found that older adults had a 
significant attenuation in the forearm blood flow response compared to younger adults 
when forearm blood flow was measured immediately after forearm contraction.  
Interestingly, the differences in forearm blood flow responses were no longer present 
when both age groups had nitric oxide synthase inhibition.  This finding suggests that 
older adults have decreased bioavailability of nitric oxide or decreased responsiveness 
to nitric oxide.  However, other studies failed to find age-associated differences after 
performing dynamic forearm exercise (26, 39).  Therefore, different mechanisms may 
influence forearm blood flow responses at the rapid onset of exercise vs. during exercise 
vs. after exercise.  Part of the reason differences were not found in this study may be 
that venous plethysmography may not have been sensitive enough to detect differences 
between individuals.  There was large variability among participants and a fairly low 
ICC was calculated among the different visits (ICC=0.69).  Furthermore, differences 
may not have been detected due to the timing of the measurement.  Forearm blood flow 
measurements were performed last (~15-20 minutes after exercise).  Future studies 
should employ a simpler protocol of performing upper body exercises and then 
measuring forearm blood flow at multiple time points to more accurately determine age 
differences in forearm blood flow.  Overall, it appears that all age groups significantly 
increased forearm blood flow following whole body resistance exercise, with greater 





Chapter V: Conclusions 
Purpose 
The purpose of this study was to determine the influence of age on arterial 
stiffness, AIx, AP, central and peripheral blood pressures, SV, EF, Q, FBF and FVC 




1. It was hypothesized that between the ages of 18-39 years, a significant increase 
in cardiovascular measures would be found post-exercise.  
Individuals between 18-39 yrs did have a significant increase in pSBP, AP, AIx, 
HR, Q, FBF, and FVC.  However, cSBP, cPWV, SV and EF were not significantly 
elevated following resistance exercise.  In addition, pPWV significantly declined 
similarly among all age groups.   
2. It was hypothesized that, after the age of 40 years, an attenuated response in 
cardiovascular measures would be observed when compared to individuals 
younger than 40 years. 
After performing resistance exercise a significant attenuation was found for AP, 
AIx, HR, FBF and FVC.  However, no significant differences were found between age 
groups for pSBP, pDBP, cSBP, cDBP, cPWV, and pPWV.   
Subquestion 
1. It was hypothesized that greater muscle mass would result in greater increases in 
arterial stiffness due to an increased load on the arterial system after an acute 
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bout of resistance exercise, but that arterial stiffness measures would be greater 
at rest for individuals with smaller muscle mass.   
No significant association was found between the amount of muscle mass and 
arterial stiffness levels.  
Strengths and Limitations 
Several limitations exist for this study.  First, a large age range for each group 
makes it difficult to exactly decipher at what age differences become apparent.  
However, it appears that around the age of 40-50 yrs, changes start to become 
measurable.  Another limitation is that the results from this study are limited to 
recreationally active males and results could be different when examining non-trained, 
aerobic-trained or resistance-trained individuals.  Also, this is an acute study so 
conclusions cannot be made about chronic adaptations.   One limitation that may have 
affected the results was that participants were tested at different times of the day.  
However, each individual was tested at the same time of day.  Only having one time 
during the day would have made it very difficult for recruiting and time management of 
the study due to the great length of time needed for each visit (1 ½ -2 hours).  
Some strengths of this study include that it does cover a wide range of ages from 
18-75 yrs.  Furthermore, it is the first study to examine how age influences multiple 
cardiovascular measures when participants perform moderate-resistance exercise.    
Significance 
With aging, there is a substantial decline in muscle mass.  Resistance exercise is 
an effective means to attenuate these declines in muscle mass and function.  However, 
the response of the cardiovascular system, and the vascular system in particular, to 
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resistance training is unclear.  Chronic training studies report increases, decreases and 
no change in arterial stiffness.  These studies have consisted of various age groups and 
different exercise intensities, making it difficult to decipher what variable may be 
affecting the arterial stiffness adaptations.  One way to decipher how these variables 
may influence the arterial stiffness adaptations to resistance exercise may be to 
investigate the acute changes in arterial stiffness following resistance exercise.  This is 
the first study to use multiple age groups using the same relative exercise intensity to 
investigate how an acute bout of resistance exercise changes arterial stiffness.   
Conclusions 
 After performing a resistance training session, younger individuals have an 
overall greater cardiovascular response compared to middle-aged and older-aged adults.  
However, when performing moderate resistance exercise, the changes in cPWV do not 
appear significant for young-aged, middle-aged or older-aged individuals, although AIx 
only increased significantly in the YG.  Thus, the transient changes in arterial stiffness 
in response to an acute moderate-intensity resistance exercise session may not be 
significant in middle-aged and older-aged adults.  Performing resistance training at 
moderate intensity may be a viable option for middle-aged and older adults to improve 
muscle mass and function without producing large changes in arterial stiffness.   
Future Research Directions 
Future studies should examine how intensity plays a role in the arterial response 
to a resistance training session.  In addition, studies examining how exercise volume 
affects the acute responses to resistance training at varying intensities are needed to help 
explain differences found in chronic studies.  Also, more studies are needed to 
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determine the mechanisms explaining how the arterial system responds to resistance 
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Appendix B: Pre-Screening Form, Medical Clearance, PAR-Q and 






















Appendix C: Sample Data Collection Forms 
Subject ID________ 
DATE: _______ TIME: ________ 
 
Visit 1 Flow List 
 Forms (~30 minutes) 
 Exclusion Criteria 
 Consent Form 
 HIPAA Form 
 PAR-Q 
 HSQ 
 Birth date __________ if younger than 18 yrs or older than 75 yrs 
exclude                                                                                                                                                 
 Patient lie on table for 5 minutes (~15 minutes) 
 Blood pressure: 1)________mmHg, 2)_________mmHg 
 Make sure less than 5 mmHg different 
 Measure ankle brachial index (ankle/brachial: if <0.9 exclude) Ankle 
will be higher than arm.  
 right arm ________ 
 right leg _______ (Right ABI:______) 
 left leg _______ 
 left arm _______ (Left ABI:______) 
 Height (cm)_______ 
 Weight (kg)_______ 
 BMI (kg/m2) ________ 
 Familiarization with machine exercises and 1-RM 
 Start with light weight. Do 8-10 reps.  Rest 1 minute.  
 Increase weight slightly 
 Perform 5 reps.  
 Move to next exercise 
 Order of exercises (Leg press, chest press, leg flexion, lat pulldown, leg 
extension) 
 Write seat adjustments for exercise on Visit 2 sheet.  
 Schedule next visits 
 Reminders for visit 2 
 Wear shorts and a t-shirt that you can exercise in and that doesn’t have 
any plastic, metal, or reflection material 
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 Do not exercise 24 hours prior to coming 
 Well hydrated.  
Visit 2 ID#:_______ 
Date: ______; Time______ 
 Calibrate DEXA and Spectrometer  
 DEXA: use phantom 
 Spectrometer: use deionized water with value reading 1.000.  
 Urine Sample/Urine Specific Gravity________    
 If more than 1.029, drink some water and wait 30 minutes to test again 
 If less than 1.004, reschedule because too hydrated       
 Record on sheet 
 Put in ID in ultrasound machine  
 Patient ID: RD (#) 
 Patient Name: Visit 2 MTH 
 Muscle Thickness (~15 minutes) Ask participant to keep marks. Freq set at 
6.0, F5 set at 40. Adjust gain if needed.  
 Arms: 60% between acromion process and lateral epicondyle of 
humerus. 
 Total Distance______ cm, 60% distance________ 
 Legs: 50% between greater trochanter and lateral epicondyle of femur. 
Rectus Femoris should be in middle of picture for ant.  
 Total Distance_______ cm, 50% distance ________ 
 Anterior Leg_____, _______ 
 Posterior Leg_____, _______ 
 Anterior Arm______, _______ 
 Posterior Arm______, _______ 
 DEXA Scan (~15 minutes) 
 Weight______. 
 Enter subject information in DXA lab book and computer. 
 Enter in first name: Dissertation,  
 Enter in last name: Rob,  
 Enter ID: RD_ _. 
 Enter height____, weight____, birthdate____, gender, race 
 Prepare subject for DXA scan 
 Remove any jewelry, plastic, metal rings etc. that might affect 
scan. Remove shoes. Should have shorts and t-shirt.  
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 Explain safety features 
 Line up subject straight on scanner 
 Explain what will happen during scan and to relax and not move.  
 Move scanner back to home position. Ctrl H.  
 Analyze Scan-ROI, Save Scan  
 Check bone density 
 If t-score less than -1.5 talk to Dr. Deb.  
 Print off  
 Perform 1-RM tests (Make sure good form, don’t overestimate 1RM because 
of bad form) 
 Estimate 50% perform 8-10 times, rest 1 minute 
 Increase weight, perform 3-5 times, then rest ~ 1-2 minutes  
 Perform 1 RM estimate.   






Trials # of 
machine 
positions 
1 2 3 4 5 



















      Back: 
Leg: 
 
Reminders for visit 3: 
Wear shorts/t-shirt 
No exercise 24 hours prior to testing 
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No alcohol or caffeine 12 hours prior to testing 
No eating 3 hours prior to testing 
Visit 3 ID#:________ 
Date: __________ Time: __________ Temperature: _________ 
Exercise Visit _________   Control Visit __________ 
Pre-exercise Measurements (~30-40 minutes) 
 Turn on sphygmacor computer, Hokanson computer:  
 Sphygmacor: stiffness 
 Turn on sphygmacor and then computer 
 Enter subject information 
1. Last Name: Dissertation 
2. First Name: Rob 
3. ID: RD_ _ 
4. Birthdate:  
 Hokanson: blood 
 Turn on from bottom to top (wait until after PWV measurements) 
 Enter subject information 
1. Last Name: Dissertation 
2. First Name Rob 
3. ID: 100-00-00_ _. 
4. Birthdate:  
 Place muscle thickness probe on ultrasound machine 
 Put in ID in ultrasound machine  
 Patient ID: RD (#) 
 Patient Name: Visit 3 MTH 
 Muscle Thickness (~15 minutes) Ask participant to keep marks. Freq set at 
6.0, F5 set at 40. Adjust gain if needed.  
 Arms: 60% between acromion process and lateral epicondyle of 
humerus. 
 60% distance________ 
 Legs: 50% between greater trochanter and lateral epicondyle of femur. 
Rectus Femoris should be in middle of picture for ant. Bone hard to see 
on back of leg. 
 50% distance________ 
 Anterior Leg_____, _______ 
 Posterior Leg_____, _______ 
 Anterior Arm______, _______ 
113 
 
 Posterior Arm______, ______ 
 Participant lies on table for ~10 minutes 
 Measure distance from carotid pulse to sternal notch 
 Distance: ___________ 
 Measure distance from sternal notch to radial pulse 
 Distance: ___________ 
 Sternal-radial minus carotid-sternal = ___________ (Carotid-
Radial distance) 
 Measure distance from sternal notch to femoral pulse 
 Distance: ___________ 
 Sternal-femoral minus carotid-sternal = __________ 
(Carotid-Femoral distance) 
 Measure distance from around largest part of forearm 
 Distance from radial tuberosity: ___________ 
 Circumference: _______, Circumference-2=__________ 
 Clean hair from chest, wipe with alcohol, let dry, and place electrodes 
 Change ultrasound probe to heart probe 
 Take blood pressure at ~7-8 minutes on right arm (take three if needed). <5 
mmHg apart 
 BP1:____/_____mmHg, BP2:____/____mmHg  
 Avg.: ______/______ mmHg  
 Cardiovascular measurements (Tilt chin up / 45 degrees for carotid 
measurements) 
 Echocardiography: Find heart on back. Subject lie on side after PWV.  
 Pulse wave analysis  
 Put in blood pressure, put in visit 3 pre-_____(condition) 
 Make sure all variables are green.   
 Pulse wave velocity 
 Put in blood pressure, put in visit 3 pre-_____(condition) 
 Put distance for carotid-radial in computer: _________ 
 Put in blood pressure 
 Put distance for carotid-femoral in computer: ________ 
 Forearm blood flow 
 Place one pad under shoulder  
 Place two pads in shape of square and with wrist holder pad on top at the 
area of the wrist 
 Place sc-10 cuff with pressure inflator on wrist 
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 Place sc-12 cuff over arm 
 Place string gauge over forearm where mark is 
 String gauge size____________ 
 Inflate wrist cuff to 200 mmHg for 1 minute 
 After 1 minute start computer. Take 6 readings. 
 Exercise or Control Session  
 If control rest for ~25 minutes and proceed to post measurements 
 If exercise, 2-3 minutes rest between sets and exercises 
 10 reps each exercise: lower weight if they can’t get 10.  Goal is 10.  
 Warm up 1 set  8-10 reps at ~50% 1RM for Leg Press/Chest Press 
 Leg Press plates______: Machine setting:______ 
 Set 1 reps______; Set 2 reps______; Set 3 reps______ 
 Chest Press plates______: Arm_____; Seat______ 
 Set 1 reps______; Set 2 reps______; Set 3 reps______ 
 Knee Flexion plates______: Leg_____; Back_______ 
 Set 1 reps______; Set 2 reps______; Set 3 reps______ 
 Lat Pulldown plates______: Seat_______ 
 Set 1 reps______; Set 2 reps______; Set 3 reps______ 
 Knee Extension plates______: Leg______; Back______ 
 Set 1 reps______; Set 2 reps______; Set 3 reps______ 
 Post-exercise measurements 
 Participant lies on table 
 Take blood pressure at 5 minutes: ____/____mmHg; ____/____mmHg:  
 Avg: ____/____mmHg 
 Cardiovascular measurements (Put new blood pressure in sphygmacor) 
 Echocardiography: Find heart on back. Lie on side after PWV 
measurements. 
 Pulse wave analysis: Put in new BP.  Make note that it is post 
measurements.  
 Pulse wave velocity: Put in new BP. Make note that it is post 
measurements. 
 Put distance for carotid-radial in computer: _________,  
 Put distance for carotid-femoral in computer: ________ 
 Forearm blood flow 
 Place one pad under shoulder  
 Place two pads in shape of square and with wrist holder pad on top at the 
area of the wrist 
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 Place sc-10 cuff with pressure inflator on wrist 
 Place sc-12 cuff over arm 
 Place string gauge over forearm where mark is 
 String gauge size____________ 
 Inflate wrist cuff to 200 mmHg for 1 minute 
 After 1 minute start computer 
 Take 6 readings and stop. 
Pre Beat 1 Beat 2 Beat 3 Beat 4 Beat 5 
EDD 
(cm) 
     
EDV 
(ml) 
     
ESD 
(cm) 
     
ESV 
(ml) 
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HR 
(bpm) 
     
CO 
(l/min) 
     
EF (%)      
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FS (%)      
 
















Enter information into spreadsheet. FBF measured peak to peak for 3 s.  






Visit 4 ID#:_________ 
Date: __________ Time: __________ Temperature: _________ 
Exercise Visit _________   Control Visit __________ 
Pre-exercise Measurements (~30-40 minutes) 
 Turn on sphygmacor computer, Hokanson:  
 Sphygmacor: stiffness 
 Turn on sphygmacor and then computer 
 Choose subject ID___ 
 Hokanson: blood 
 Turn on from bottom to top 
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 Choose subject ID___ 
 Participant lies on table for ~10 minutes 
 Forearm blood flow distance______. Place mark there.  
 String gauge size______. 
 Clean hair from chest, wipe with alcohol, let dry, and place electrodes 
 Change ultrasound probe to heart probe 
 Take blood pressure at ~7-8 minutes on right arm (take three if needed) 
 BP1:____/____mmHg,BP2:____/____mmHg,  
 Avg.: ____/___ mmHg  
 Cardiovascular measurements (Tilt chin up / 45 degrees for carotid 
measurements) 
 Echocardiography: Find heart on back. Subject lie on side after PWV.  
 Pulse wave analysis 
 Put in blood pressure, put in visit 4 pre-_____(condition) 
 Make sure all variables are green.   
 Pulse wave velocity 
 Put in blood pressure, put in visit 4 pre-_____(condition) 
 Put distance for carotid-radial in computer: _________ 
 Put in blood pressure 
 Put distance for carotid-femoral in computer: ________ 
 Forearm blood flow.  
 Place one pad under shoulder  
 Place two pads in shape of square and with wrist holder pad on top at the 
area of the wrist 
 Place sc-10 cuff with pressure inflator on wrist 
 Place sc-12 cuff over arm 
 Place string gauge over forearm where mark is 
 Inflate wrist cuff to 200 mmHg for 1 minute 
 After 1 minute start computer 
 Take 6 readings and stop 
 Exercise or Control Session  
 If control rest for ~25 minutes and proceed to post measurements 
 If exercise, 2-3 minutes rest between sets and exercises 
 10 reps each exercise: lower weight if they can’t get 10.  Goal is 10.  
 Warm up 1 set  8-10 reps at ~50% 1RM for Leg Press/Chest Press 
 Leg Press plates______: Machine setting:______ 
 Set 1 reps______; Set 2 reps______; Set 3 reps______ 
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 Chest Press plates______: Arm_____; Seat______ 
 Set 1 reps______; Set 2 reps______; Set 3 reps______ 
 Knee Flexion plates______: Leg_____; Back_______ 
 Set 1 reps______; Set 2 reps______; Set 3 reps______ 
 Lat Pulldown plates______: Seat_______ 
 Set 1 reps______; Set 2 reps______; Set 3 reps______ 
 Knee Extension plates______: Leg______; Back______ 
 Set 1 reps______; Set 2 reps______; Set 3 reps______ 
 Post-exercise measurements 
 Participant lies on table 
 Take blood pressure at 5 minutes: ____/____mmHg; ____/____mmHg:  
 Avg: ____/____mmHg 
 Cardiovascular measurements (Put new blood pressure in sphygmacor) 
 Echocardiography: Lie on side after PWV measurements.  
 Make sure good image using circle technique  
 Save 2 images so that you have 3 good heartbeats 
 Pulse wave analysis: Put in new BP.  Make note that it is post 
measurements.  
 Pulse wave velocity (Carotid-Femoral/Radial minus carotid-sternal 
distance) 
 Put distance for carotid-radial in computer: _________ 
 Put distance for carotid-femoral in computer: ________ 
 Forearm blood flow 
 Place one pad under shoulder  
 Place two pads in shape of square and with wrist holder pad on top at the 
area of the wrist. Place sc-10 cuff with pressure inflator on wrist.  Place 
sc-12 cuff over arm 
 Place string gauge over forearm where mark is 
 Inflate wrist cuff to 200 mmHg for 1 minute 
 After 1 minute start computer, take 6 readings, then stop 
Pre Beat 1 Beat 2 Beat 3 Beat 4 
EDD (cm)     
EDV (ml)     
ESD (cm)     
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ESV (ml)     
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HR (bpm)     
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Post Beat 1 Beat 2 Beat 3 Beat 4 
EDD (cm)     
EDV (ml)     
ESD (cm)     
ESV (ml)     
SV (ml)     
HR (bpm)     
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EF (%)     
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Pre: Forearm Blood Flow 
Measurement 









Post: Forearm Blood Flow 
Measurement 




















Leg Press 1-RM plates (1 plate = 
20 lbs) 
Leg Press 1-RM 
pounds 
Leg Press 1-RM 
(kg)  
Leg Press 65% 
1RM (lb) 
RD1 28.0 1 24 + 3 reps 446.0 202.7 312.0 
RD2 65.9 3 14.5 289.6 131.6 188.2 
RD3 27.7 1 15.5 309.6 140.7 201.0 
RD4 60.0 3 15.5 309.6 140.7 201.0 
RD5 22.5 1 14.0 280.0 127.3 182.0 
RD6 32.8 1 17.5 349.6 158.9 227.2 
RD7 72.3 3 17.0 340.0 154.6 221.0 
RD8 75.6 3 10.0 200.0 90.9 130.0 
RD9 43.2 2 15.0 300.0 136.4 195.0 
RD10 74.9 3 12.0 240.0 109.1 156.0 
RD11 26.8 1 14.5 289.6 131.6 188.2 
RD12 22.5 1 16.5 329.6 149.8 214.2 
RD13 71.2 3 13.5 269.6 122.6 175.2 
RD14 46.0 2 14.5 289.6 131.6 188.2 
RD15 27.2 1 18.5 369.6 168.0 240.2 
RD16 49.8 2 16.0 320.0 145.5 208.0 
RD17 61.2 3 15.5 309.6 140.7 201.0 
RD18   
 
        
RD19   
 
        
RD20 47.3 2 11.0 220.0 100.0 143.0 
RD21   
 
        
RD22 21.7 1 19.5 389.6 177.1 253.2 
RD23 60.3 3 10.0 200.0 90.9 130.0 
RD24 61.3 3 11.0 220.0 100.0 143.0 
RD25   
 
        
RD26 56.1 2 15.0 300.0 136.4 195.0 
RD27 53.5 2 12.5 249.6 113.5 162.2 
RD28 46.8 2 17.0 340.0 154.6 221.0 
RD29 27.0 1 15.0 300.0 136.4 195.0 
RD30 29.0 1 19.0 380.0 172.7 247.0 
RD31 29.8 1 19.5 389.6 177.1 253.2 
RD32 27.2 1 13.5 269.6 122.6 175.2 
RD33 57.2 2 16.5 329.6 149.8 214.2 
RD34 48.8 2 15.5 309.6 140.7 201.0 
RD35   
 
        
RD36 71.1 3 10.5 209.6 95.3 136.2 
RD37 51.6 2 12.0 240.0 109.1 156.0 
RD38 40.8 2 25.0 500.0 227.3 325.0 
RD39 44.0 2 17.0 340.0 154.6 221.0 
RD40 48.9 2 14.0 280.0 127.3 182.0 
RD41 57.0 2 11.0 220.0 100.0 143.0 
RD42   
 
14.0 280.0 127.3 182.0 













Sets Weight Used 
(lbs) 
Sets Weight Used 
(kg) 
Total Volume (Weight 
(kg)xSetsxReps) 
          
140.0 63.6 180.0 81.8 3090.9 
149.6 68.0 209.6 95.3 3538.2 
149.6 68.0 200.0 90.9 3407.3 
140.0 63.6 180.0 81.8 3090.9 
169.6 77.1 229.6 104.4 3901.8 
169.6 77.1 220.0 100.0 3588.9 
100.0 45.5 129.6 58.9 2221.8 
149.6 68.0 189.6 86.2 3265.5 
120.0 54.5 149.6 68.0 2585.5 
140.0 63.6 189.6 86.2 3221.8 
160.0 72.7 209.6 95.3 3585.5 
129.6 58.9 169.6 77.1 2901.8 
140.0 63.6 180.0 81.8 3090.9 
180.0 81.8 240.0 109.1 4090.9 
160.0 72.7 200.0 90.9 3454.5 
149.6 68.0 200.0 90.9 3407.3 
  0.0   0.0 0.0 
  0.0   0.0 0.0 
109.6 49.8 140.0 63.6 2407.3 
  0.0   0.0 0.0 
200.0 90.9 249.6 113.5 4312.7 
100.0 45.5 129.6 58.9 2221.8 
109.6 49.8 140.0 63.6 2407.3 
  0.0   0.0 0.0 
149.6 68.0 169.6 77.1 2992.7 
120.0 54.5 160.0 72.7 2727.3 
169.6 77.1 209.6 95.3 3629.1 
149.6 68.0 189.6 86.2 3265.5 
189.6 86.2 240.0 109.1 4134.5 
189.6 86.2 249.6 113.5 4265.5 
129.6 58.9 169.6 77.1 2901.8 
160.0 72.7 209.6 95.3 3585.5 
149.6 68.0 200.0 90.9 3407.3 
  0.0   0.0 0.0 
100.0 45.5 140.0 63.6 2363.6 
120.0 54.5 149.6 68.0 2585.5 
249.6 113.5 320.0 145.5 5498.2 
169.6 77.1 220.0 100.0 3770.9 
140.0 63.6 180.0 81.8 3090.9 
110.0 50.0 140.0 63.6 2536.4 
140.0 63.6   0.0 636.4 













Chest Press 1-RM 
(kg) 




Sets Weight Used 
(kg) 
Total Volume (Weight 
(kg)xSetsxReps) 
79.0 52.0       
45.5 30.7 20.2 27.2 1018.0 
58.5 38.0 27.2 38.5 1427.0 
47.0 30.6 20.2 31.5 1127.5 
56.4 36.7 20.2 32.7 1183.0 
67.5 43.9 31.5 45.0 1665.0 
79.0 52.0 38.5 47.2 1801.0 
45.0 29.3 20.2 27.2 1018.0 
76.9 50.0 38.5 52.0 1945.0 
52.0 33.8 25.0 31.5 1195.0 
67.5 43.0 31.5 45.0 1665.0 
93.0 60.5 45.0 58.5 2205.0 
52.0 33.8 25.0 31.5 1195.0 
65.5 42.6 31.5 40.7 1492.0 
81.2 52.8 38.5 52.0 1945.0 
100.0 65.0 47.2 65.5 2367.0 
85.5 55.6 40.7 52.0 1967.0 
        0.0 
        0.0 
60.7 39.5 31.5 38.5 1470.0 
        0.0 
106.0 68.9 52.0 67.7 2551.0 
38.5 25.0 18.0 25.0 930.0 
52.0 33.8 25.0 31.5 1195.0 
        0.0 
93.5 60.8 45.0 58.5 2205.0 
60.7 39.5 31.5 38.5 1470.0 
100.0 65.0 52.0 60.7 2341.0 
74.7 48.6 33.7 47.2 1623.0 
93.0 60.5 47.2 58.5 2227.0 
85.5 55.6 40.7 54.2 2012.0 
52.0 33.8 25.0 31.5 1195.0 
65.5 42.6 31.5 40.7 1536.0 
72.5 47.1 38.5 45.0 1735.0 
        0.0 
58.0 37.7 27.2 31.5 1217.0 
67.7 44.0 33.7 40.7 1558.0 
81.7 57.0 40.7 54.2 2033.0 
87.7 57.0 40.7 54.2 2033.0 
65.5 42.6 31.5 40.7 1536.0 
45.0 29.3 20.2 27.2 1018.0 
58.5 38.0 27.2   272.0 


























20.0 250.0 113.6 175.0     
12.0 150.0 68.2 97.5 93.5 42.5 
16.0 200.0 90.9 130.0 131.0 59.5 
14.5 181.0 82.3 117.7 118.5 53.9 
13.5 168.8 76.7 109.7 106.0 48.2 
12.5 156.3 71.0 101.6 100.0 45.5 
10.5 131.0 59.6 85.2 81.0 36.8 
10.5 131.0 59.6 85.2 81.0 36.8 
13.5 168.8 76.7 109.7 106.0 48.2 
12.0 150.0 68.2 97.5 93.5 42.5 
11.5 143.5 65.2 93.3 93.5 42.5 
13.5 168.8 76.7 109.7 106.0 48.2 
11.5 143.5 65.2 93.3 93.5 42.5 
15.0 187.5 85.2 121.9 118.5 53.9 
15.0 187.5 85.2 121.9 118.5 53.9 
17.5 218.5 99.3 142.0 137.5 62.5 
13.0 162.5 73.9 105.6 106.0 48.2 
          0.0 
          0.0 
10.0 125.0 56.8 81.3 81.0 36.8 
          0.0 
14.0 175.0 79.6 113.8 112.5 51.1 
9.0 112.5 51.1 73.1 68.5 31.1 
11.5 143.5 65.2 93.3 87.5 39.8 
          0.0 
10.0 125.0 56.8 81.3 81.0 36.8 
13.5 168.8 76.7 109.7 106.0 48.2 
14.0 175.0 79.6 113.8 112.5 51.1 
14.0 175.0 79.6 113.8 112.5 51.1 
13.5 168.8 76.7 109.7 106.0 48.2 
15.5 193.5 88.0 125.8 125.0 56.8 
10.0 125.0 56.8 81.3 81.0 36.8 
14.0 175.0 79.6 113.8 112.5 51.1 
10.5 131.0 59.6 85.2 81.0 36.8 
          0.0 
11.5 143.5 65.2 93.3 93.5 42.5 
15.5 193.5 88.0 125.8 125.0 56.8 
16.5 206.0 93.6 133.9 131.0 59.5 
15.0 187.5 85.2 121.9 118.5 53.9 
15.0 187.5 85.2 121.9 118.5 53.9 
8.0 100.0 45.5 65.0 62.5 28.4 
13.0 162.5 73.9 105.6   0.0 













Total Volume (Weight 
(kg)xSetsxReps) 
Lat Pulldown 1-RM 











  14.0 175.0 79.6 113.8   
1275.0 9.0 112.5 51.1 73.1 68.9 
1735.3 11.5 143.9 65.4 93.5 93.9 
1615.9 11.5 143.9 65.4 93.5 93.9 
1445.5 10.5 131.4 59.7 85.4 81.4 
1363.6 13.0 162.5 73.9 105.6 106.4 
1104.5 13.0 162.5 73.9 105.6 106.4 
1104.5 12.0 150.0 68.2 97.5 93.9 
1445.5 13.0 162.5 73.9 105.6 106.4 
1275.0 9.5 118.9 54.1 77.3 75.0 
1275.0 10.0 125.0 56.8 81.3 81.4 
1445.5 14.5 181.4 82.5 117.9 118.9 
1275.0 10.5 131.4 59.7 85.4 81.4 
1615.9 11.5 143.9 65.4 93.5 93.9 
1615.9 15.0 187.5 85.2 121.9 118.9 
1875.0 14.5 181.4 82.5 117.9 118.9 
1445.5 13.0 162.5 73.9 105.6 106.4 
0.0           
0.0           
1104.5 9.5 118.9 54.1 77.3 75.0 
0.0           
1534.1 14.0 175.0 79.6 113.8 112.5 
934.1 8.5 106.4 48.4 69.2 68.5 
1193.2 9.5 118.9 54.1 77.3 75.0 
0.0           
1104.5 14.0 175.0 79.6 113.8 112.5 
1445.5 11.5 143.9 65.4 93.5 93.9 
1534.1 16.0 201.6 91.6 131.0 131.4 
1534.1 11.5 143.9 65.4 93.5 93.9 
1445.5 11.5 143.9 65.4 93.5 93.9 
1704.5 15.0 187.5 85.2 121.9 118.9 
1104.5 10.5 131.4 59.7 85.4 81.4 
1534.1 11.0 137.5 62.5 89.4 87.5 
1104.5 12.0 150.0 68.2 97.5 93.9 
0.0           
1323.5 12.0 150.0 68.2 97.5 93.9 
1704.5 13.0 162.5 73.9 105.6 106.4 
1786.4 12.0 150.0 68.2 97.5 93.9 
1615.9 13.5 168.9 76.8 109.8 106.4 
1615.9 12.0 150.0 68.2 97.5 93.9 
852.3 8.5 106.4 54.1 69.2 68.9 
0.0 12.0 150.0 68.2 97.5   















Total Volume (Weight 
(kg)xSetsxReps) 
Knee Extension 1-RM 








    20.0 250.0 113.6 175.0 
31.3 939.5 10.5 131.2 59.6 85.3 
42.7 1280.5 14.5 181.3 82.4 117.8 
42.7 1280.5 14.5 181.3 82.4 117.8 
37.0 1110.0 12.5 156.2 71.0 101.5 
48.4 1450.9 14.5 181.3 82.4 117.8 
48.4 1450.9 12.5 156.2 71.0 101.5 
42.7 1280.5 8.5 106.2 48.3 69.0 
48.4 1450.9 14.5 181.3 82.4 117.8 
34.1 1022.7 10.0 125.0 56.8 81.3 
37.0 1110.0 13.5 168.7 76.7 109.7 
54.0 1621.4 15.0 187.5 85.2 121.9 
37.0 1110.0 10.5 131.2 59.6 85.3 
42.7 1280.5 15.5 193.7 88.0 125.9 
54.0 1621.4 17.5 218.7 99.4 142.2 
54.0 1621.4 15.5 193.7 88.0 125.9 
48.4 1450.9 13.0 162.5 73.9 105.6 
0.0 0.0         
0.0 0.0         
34.1 1022.7 10.0 125.0 56.8 81.3 
0.0 0.0         
51.1 1534.1 14.0 175.0 79.6 113.8 
31.1 934.1 8.0 100.0 45.5 65.0 
34.1 1022.7 8.5 106.2 48.3 69.0 
0.0 0.0         
51.1 1534.1 12.5 156.2 71.0 101.5 
42.7 1280.5 15.0 187.5 85.2 121.9 
59.7 1791.8 9.0 112.5 51.1 73.1 
42.7 1280.5 16.5 206.2 93.7 134.0 
42.7 1280.5 14.5 181.3 82.4 117.8 
54.0 1621.4 17.0 212.5 96.6 138.1 
37.0 1110.0 10.0 125.0 96.6 81.3 
39.8 1193.2 10.0 125.0 56.8 81.3 
42.7 1280.5 11.0 137.5 62.5 89.4 
0.0 0.0         
42.7 1280.5 10.5 131.2 59.6 85.3 
48.4 1450.9 13.5 168.7 76.7 109.7 
42.7 1280.5 19.0 237.5 108.0 154.4 
48.4 1450.9 16.5 206.2 93.7 134.0 
42.7 1280.5 13.5 168.7 76.7 109.7 
31.3 939.5 8.5 106.2 48.3 69.0 
0.0 0.0 10.5 131.2 59.6 85.3 













Sets Weight Used (lbs) Sets Weight Used (kg) Total Volume (Weight (kg)xSetsxReps) 
Total Exercise Volume 
(kg) 
        
81.2 36.9 1107.3 7430.7 
118.7 54.0 1618.6 9599.6 
118.5 53.9 1615.9 9047.0 
100.0 45.5 1363.6 8193.0 
118.7 54.0 1618.6 10000.0 
100.0 45.5 1363.6 9309.0 
68.7 31.2 936.8 6561.6 
118.7 54.0 1618.6 9725.5 
81.2 36.9 1107.3 7185.5 
106.2 48.3 1448.2 8720.0 
118.7 54.0 1618.6 10475.9 
0.0 0.0 0.0 6481.8 
125.0 56.8 1704.5 9183.8 
137.5 62.5 1818.0 11091.2 
125.0 56.8 1704.5 11022.5 
106.2 48.3 1448.2 9718.8 
  0.0 0.0 0.0 
  0.0 0.0 0.0 
81.2 36.9 1107.3 7111.8 
  0.0 0.0 0.0 
112.5 51.1 1534.1 11466.0 
62.5 28.4 852.3 5872.3 
68.7 31.2 824.3 6642.5 
  0.0 0.0 0.0 
100.0 45.5 1192.5 9028.9 
118.7 54.0 1618.6 8541.8 
68.7 31.2 936.8 10232.8 
112.5 51.1 1307.4 9010.4 
112.5 51.1 1534.1 10621.5 
137.5 62.5 1875.0 11478.4 
87.5 39.8 1193.2 7504.5 
81.2 36.9 1107.3 8956.0 
87.5 39.8 1193.2 8720.5 
  0.0 0.0 0.0 
81.2 36.9 1107.3 7291.9 
106.2 48.3 1363.5 8662.4 
240.0 109.1 2908.9 13506.9 
131.2 59.6 1675.6 10546.3 
106.2 48.3 1448.2 8971.5 
68.7 31.2 936.8 6283.0 
  0.0 0.0 908.4 































RD1 28.0 1 5.72 5.74 5.73 5.92 5.94 5.93 
RD2 65.9 3 5.78 5.78 5.78 6.86 6.82 6.84 
RD3 27.7 1 6.14 6.05 6.10 4.73 4.78 4.76 
RD4 60.0 3 5.87 5.87 5.87 5.81 5.81 5.81 
RD5 22.5 1 5.08 5.12 5.10 6.56 6.58 6.57 
RD6 32.8 1 6.08 6.1 6.09 4.84 4.86 4.85 
RD7 72.3 3 4.24 4.16 4.20 5.36 5.36 5.36 
RD8 75.6 3 3.82 3.8 3.81 5.87 5.90 5.89 
RD9 43.2 2 4.52 4.59 4.56 5.96 6.17 6.07 
RD10 74.9 3 4.86 4.9 4.88 6.12 6.06 6.09 
RD11 26.8 1 4.83 4.87 4.85 5.37 5.39 5.38 
RD12 22.5 1 5.37 5.41 5.39 5.92 5.95 5.94 
RD13 71.2 3 4.82 4.82 4.82 6.64 6.60 6.62 
RD14 46.0 2 5.46 5.48 5.47 6.10 6.12 6.11 
RD15 27.2 1 6.08 6.06 6.07 6.12 6.12 6.12 
RD16 49.8 2 4.9 4.9 4.90 6.40 6.40 6.40 
RD17 61.2 3 4.5 4.5 4.50 5.85 5.93 5.89 
RD18   
 
            
RD19   
 
            
RD20 47.3 2 4.57 4.53 4.55 5.80 5.80 5.80 
RD21   
 
            
RD22 21.7 1 5.98 5.98 5.98 6.48 6.46 6.47 
RD23 60.3 3 3.86 3.86 3.86 5.01 5.02 5.02 
RD24 61.3 3 4.17 4.22 4.20 5.57 5.65 5.61 
RD25   
 
            
RD26 56.1 2 5.06 5.06 5.06 5.79 5.76 5.78 
RD27 53.5 2 4.32 4.29 4.31 6.22 6.30 6.26 
RD28 46.8 2 5.09 5.09 5.09 5.98 5.98 5.98 
RD29 27.0 1 4.81 4.83 4.82 6.40 6.36 6.38 
RD30 29.0 1 5.02 5.02 5.02 5.92 5.92 5.92 
RD31 29.8 1 5.8 5.8 5.80 6.62 6.57 6.60 
RD32 27.2 1 4.62 4.64 4.63 6.75 6.75 6.75 
RD33 57.2 2 4.59 4.64 4.62 5.74 5.72 5.73 
RD34 48.8 2 5.82 5.8 5.81 6.84 6.62 6.73 
RD35   
 
            
RD36 71.1 3 4.17 
 
4.17 7.22 7.27 7.25 
RD37 51.6 2 4.74 4.74 4.74 5.16 5.24 5.20 
RD38 40.8 2 6.34 6.42 6.38 6.17 6.19 6.18 
RD39 44.0 2 5.51 5.44 5.48 5.96 6.00 5.98 
RD40 48.9 2 5.55 5.58 5.57 6.32 6.32 6.32 
RD41 57.0 2 4.52 4.48 4.50 5.18 5.24 5.21 
RD42   
 
            
































3.66 3.63 3.65 4.32 4.22 4.27 5.78 5.78 5.78 
4.28 4.26 4.27 3.36 3.48 3.42 5.62 5.6 5.61 
3.8 3.78 3.79 3.89 3.94 3.92 5.94 5.96 5.95 
4.22 4.22 4.22 4.08 4.17 4.13 5.58 5.8 5.69 
3.18 3.18 3.18 3.05 3.07 3.06 5.24 5.28 5.26 
3.23 3.32 3.28 4.15 4.19 4.17 6.38 6.38 6.38 
3.99 3.97 3.98 3.90 3.94 3.92 4.29 4.41 4.35 
3.78 3.86 3.82 3.83 3.93 3.88 3.73 3.78 3.76 
4.45 4.52 4.49 3.78 3.76 3.77 4.67 4.62 4.65 
3.08 3.11 3.10 2.78 2.72 2.75 4.49 4.50 4.50 
3.31 3.30 3.31 3.69 3.71 3.70 4.74 4.78 4.76 
3.05 3.10 3.08 4.55 4.55 4.55 5.13 5.08 5.11 
3.72 3.74 3.73 2.53 2.53 2.53 4.81 4.78 4.80 
3.10 3.02 3.06 3.34 3.28 3.31 5.36 5.30 5.33 
3.52 3.52 3.52 3.76 3.75 3.76 6.01 5.96 5.99 
4.16 4.14 4.15 4.43 4.41 4.42 4.95 5.01 4.98 
3.96 3.94 3.95 4.17 4.06 4.12 4.60 4.60 4.60 
                  
                  
2.94 2.94 2.94 3.56 3.54 3.55 4.80 4.78 4.79 
                  
3.64 3.69 3.67 4.55 4.55 4.55 6.14 6.20 6.17 
3.53 3.60 3.57 1.49 1.50 1.50 3.80 3.81 3.81 
3.71 3.66 3.69 3.42 3.41 3.42 4.48 4.40 4.44 
                  
4.38 4.35 4.37 4.39 4.39 4.39 5.17 5.18 5.18 
3.78 3.74 3.76 3.50 3.47 3.49 4.52 4.50 4.51 
4.81 4.85 4.83 3.99 3.96 3.98 5.13 5.18 5.16 
3.44 3.47 3.46 3.68 3.69 3.69 4.85 4.83 4.84 
4.02 3.99 4.01 4.66 4.69 4.68 5.04 5.06 5.05 
3.83 3.82 3.83 4.08 4.10 4.09 5.92 5.92 5.92 
3.26 3.31 3.29 3.21 3.21 3.21 4.95 4.95 4.95 
3.78 3.75 3.77 3.21 3.24 3.23 4.66 4.60 4.63 
4.20 4.20 4.20 3.92 3.99 3.96 5.32 5.28 5.30 
                  
3.83 3.86 3.85 3.27 3.33 3.30 4.22 4.22 4.22 
3.60 3.60 3.60 3.80 3.75 3.78 5.01 5.04 5.03 
3.80 3.84 3.82 4.10 4.05 4.08 6.44 6.40 6.42 
4.35 4.41 4.38 4.57 4.55 4.56 5.92 5.94 5.93 
3.62 3.63 3.63 4.96 4.92 4.94 5.86 5.88 5.87 
3.65 3.52 3.59 3.75 3.69 3.72 4.83 4.81 4.82 
                  
































5.94 6.01 5.98 3.66 3.74 3.70 4.25 3.89 (bad) 4.25 
6.44 6.44 6.44 4.26 4.23 4.25 3.36 3.38 3.37 
4.73 4.75 4.74 4.04 4.03 4.04 3.71 3.73 3.72 
5.6 5.64 5.62 4.14 4.14 4.14 4.22 4.15 4.19 
6.24 6.28 6.26 3.03 3.01 3.02 3.33 3.31 3.32 
4.68 4.66 4.67 3.30 3.33 3.32 4.23 4.20 4.22 
4.99 5.08 5.04 4.08 4.04 4.06 3.90 3.95 3.93 
6.02 6.00 6.01 3.47 3.44 3.46 3.62 3.59 3.61 
x x #DIV/0! 4.37 4.28 4.33 3.95 3.92 3.94 
5.69 5.74 5.72 3.06 3.03 3.05 2.75 2.87 2.81 
5.51 5.46 5.49 3.30 3.30 3.30 3.59 3.60 3.60 
5.64 5.69 5.67 3.26 3.21 3.24 4.52 4.50 4.51 
6.73 6.73 6.73 4.01 3.99 4.00 2.70 2.73 2.72 
5.93 5.79 5.86 3.19 3.23 3.21 3.11 3.08 3.10 
6.24 6.26 6.25 3.72 3.74 3.73 3.42 3.53 3.48 
6.56 6.56 6.56 4.10 4.10 4.10 4.66 4.64 4.65 
6.48 6.44 6.46 3.78 3.80 3.79 4.17 4.15 4.16 
                  
                  
5.43 5.47 5.45 3.27 3.21 3.24 3.47 3.51 3.49 
                  
6.48 6.53 6.51 3.81 3.79 3.80 4.38 4.53 4.46 
4.95 4.96 4.96 3.55 3.51 3.53 1.80 1.88 1.84 
5.28 5.32 5.30 3.73 3.71 3.72 3.30 3.24 3.27 
                  
6.22 6.20 6.21 4.14 4.13 4.14 4.64 4.64 4.64 
6.14 6.14 6.14 3.59 3.54 3.57 3.87 3.84 3.86 
5.90 5.91 5.91 4.73 4.71 4.72 4.35 4.38 4.37 
6.89 6.89 6.89 3.54 3.54 3.54 3.56 3.50 3.53 
6.19 6.19 6.19 3.87 3.92 3.90 4.50 4.52 4.51 
6.53 6.42 6.48 3.83 3.83 3.83 4.36 4.31 4.34 
6.64 6.60 6.62 3.26 3.24 3.25 3.33 3.40 3.37 
5.88 5.79 5.84 3.55 3.62 3.59 3.54 3.53 3.54 
6.80 6.75 6.78 4.22 4.27 4.25 3.90 3.92 3.91 
                  
6.93 7.29 7.11 3.90 3.90 3.90 3.27 3.32 3.30 
5.16 5.23 5.20 3.54 3.56 3.55 3.78 3.80 3.79 
6.50 6.46 6.48 3.87 3.84 3.86 4.13 4.16 4.15 
6.04 6.06 6.05 4.50 4.46 4.48 4.64 4.62 4.63 
5.90 5.83 5.87 3.35 3.35 3.35 5.11 5.05 5.08 
5.32 5.33 5.33 3.68 3.57 3.63 3.77 3.73 3.75 
                  






























RD1 28.0 1 185.0 83.6 24.4 2.1 1.7 19.2 
RD2 65.9 3 174.0 77.5 25.6 1.9 2.6 19.0 
RD3 27.7 1 171.5 79.0 26.9 1.9 1.3 34.7 
RD4 60.0 3 185.0 99.1 29.0 2.2 0.5 34.1 
RD5 22.5 1 179.0 77.9 25.7 2.0 -0.9 25.7 
RD6 32.8 1 175.3 67.2 22.0 1.8 -0.3 9.1 
RD7 72.3 3 161.5 74.5 28.6 1.8 1.2 25.0 
RD8 75.6 3 173.5 69.8 23.2 1.8 2.1 23.2 
RD9 43.2 2 179.5 87.9 27.3 2.1 0.8 29.7 
RD10 74.9 3 182.0 74.9 22.6 2.0 -0.9 19.9 
RD11 26.8 1 167.0 59.3 21.3 1.7 -0.2 24.0 
RD12 22.5 1 171.5 68.6 23.3 1.8 0.1 17.2 
RD13 71.2 3 176.5 79.8 25.6 2.0 1.7 27.8 
RD14 46.0 2 190.0 74.2 20.6 2.0 -0.2 7.9 
RD15 27.2 1 189.0 89.7 25.1 2.2 1.7 23.7 
RD16 49.8 2 179.5 85.4 26.5 2.0 3.3 25.4 
RD17 61.2 3 172.5 87.6 29.4 2.0 0.9 30.9 
RD18   
 
      0.0     
RD19   
 
      0.0     
RD20 47.3 2 167.0 62.2 22.3 1.7 -0.2 19.3 
RD21   
 
      0.0     
RD22 21.7 1 178.0 78.7 24.8 2.0 2.5 17.9 
RD23 60.3 3 185.5 64.4 18.7 1.9 -0.3 12.7 
RD24 61.3 3 181.7 79.6 24.1 2.0 0.9 31.0 
RD25   
 
      0.0     
RD26 56.1 2 167.0 77.7 27.9 1.9 1.1 25.1 
RD27 53.5 2 178.0 70.4 22.2 1.9 0.8 16.2 
RD28 46.8 2 179.0 76.8 24.0 2.0 0.8 13.8 
RD29 27.0 1 172.5 77.3 26.0 1.9 1.1 22.0 
RD30 29.0 1 169.0 74.5 26.1 1.9 1.3 22.5 
RD31 29.8 1 176.0 75.8 24.5 1.9 0.1 19.1 
RD32 27.2 1 177.0 73.0 23.3 1.9 -0.6 24.9 
RD33 57.2 2 185.5 99.8 29.0 2.2 2.0 33.1 
RD34 48.8 2 173.5 89.4 29.7 2.0 1.1 35.7 
RD35   
 
      0.0     
RD36 71.1 3 182.3 69.0 20.8 1.9 3.5 12.0 
RD37 51.6 2 186.0 84.1 24.3 2.1 0.6 23.4 
RD38 40.8 2 176.5 83.3 26.7 2.0 0.3 19.6 
RD39 44.0 2 185.0 94.4 27.6 2.2 1.7 28.7 
RD40 48.9 2 177.5 80.8 25.6 2.0 0.1 16.4 
RD41 57.0 2 170.0 77.3 26.7 1.9 -0.5 36.4 
RD42   
 
      0.0     





























83.8 79969.0 15326.0 64644.0 3828.0 68471.0 24.0 23.8 
77.6 74233.0 14118.0 60115.0 3344.0 63460.0 31.3 22.2 
78.6 75134.0 26056.0 49078.0 3459.0 52537.0 37.4 46.5 
98.7 95257.0 32468.0 62789.0 3398.0 66187.0 47.1 33.6 
77.5 74877.0 19264.0 55612.0 2620.0 58233.0 35.3 31.0 
67.6 64846.0 5900.0 58947.0 2773.0 61720.0 13.1 12.2 
74.2 71207.0 17781.0 53427.0 3008.0 56435.0 39.7 24.8 
69.7 66342.0 15384.0 50958.0 3337.0 54295.0 36.3 26.1 
87.8 84366.0 25090.0 59276.0 3484.0 62760.0 40.7 35.3 
74.9 72098.0 14343.0 57755.0 2833.0 60588.0 24.9 25.9 
59.2 56549.0 13597.0 42953.0 2690.0 45643.0 30.7 29.9 
68.7 65722.0 11307.0 54415.0 2967.0 57382.0 25.2 23.3 
79.8 76344.0 21255.0 55089.0 3494.0 58583.0 41.0 28.9 
74.9 71600.0 5671.0 65929.0 3338.0 69267.0 9.8 11.6 
89.9 85864.0 20379.0 65485.0 3930.0 69415.0 32.5 29.6 
85.4 81284.0 20642.0 60643.0 4121.0 64764.0 34.7 33.2 
87.3 84027.0 25923.0 58104.0 3242.0 61346.0 43.7 34.2 
                
                
62.2 59686.0 11518.0 48167.0 2497.0 50664.0 19.1 29.7 
                
78.9 75191.0 13464.0 61728.0 3697.0 65425.0 23.7 24.0 
65.1 62220.0 7929.0 54291.0 2834.0 57125.0 15.7 20.6 
79.4 75849.0 23490.0 52359.0 3535.0 55894.0 39.8 35.3 
                
77.6 74597.0 18708.0 55890.0 3039.0 58929.0 40.3 24.1 
70.7 67700.0 10958.0 56743.0 2969.0 59712.0 22.4 21.4 
77.2 73929.0 10236.0 63693.0 3226.0 66919.0 16.1 18.7 
77.1 73665.0 16189.0 57476.0 3461.0 60937.0 27.6 28.9 
74.4 71144.0 15993.0 55151.0 3223.0 58374.0 32.6 29.6 
76.1 73001.0 13932.0 59070.0 3078.0 62148.0 22.8 26.0 
72.8 69905.0 17405.0 52500.0 2860.0 55359.0 32.1 31.2 
99.7 95703.0 31718.0 63985.0 3995.0 67980.0 45.9 33.7 
88.9 85510.0 30529.0 54981.0 3435.0 58416.0 46.7 37.8 
                
69.4 65396.0 7858.0 57538.0 4016.0 61554.0 15.5 18.1 
84.1 80440.0 18814.0 61627.0 3612.0 65239.0 30.3 29.2 
83.6 80459.0 15777.0 64682.0 3106.0 67788.0 31.6 23.9 
97.4 93643.0 26893.0 66750.0 3710.0 70460.0 41.2 30.0 
81.3 78307.0 12822.0 65485.0 2993.0 68478.0 22.4 21.9 
76.3 73681.0 26852.0 46829.0 2662.0 49491.0 50.2 37.2 
                






























1.0 11.3 8663.0 980.0 7683.0 476.0 9.1 17.1 
1.4 12.8 7486.0 962.0 6524.0 482.0 8.0 12.1 
0.8 24.3 7901.0 1922.0 5979.0 449.0 8.3 36.8 
1.4 21.0 9652.0 2029.0 7623.0 454.0 10.0 26.4 
1.1 20.4 7721.0 1575.0 6146.0 339.0 8.1 22.1 
1.1 5.6 6985.0 389.0 6595.0 332.0 7.3 8.5 
1.6 16.7 7763.0 1296.0 6467.0 428.0 8.2 16.5 
1.4 19.0 7216.0 1372.0 5843.0 478.0 7.7 19.4 
1.2 20.4 9920.0 2022.0 7898.0 511.0 10.4 28.2 
1.0 15.3 7819.0 1197.0 6623.0 428.0 8.2 21.8 
1.0 14.9 5826.0 866.0 4959.0 345.0 6.2 24.0 
1.1 10.9 7658.0 837.0 6821.0 467.0 8.1 15.6 
1.4 18.7 7883.0 1471.0 6412.0 465.0 8.3 23.0 
0.8 4.7 7586.0 354.0 7232.0 486.0 8.1 7.6 
1.1 12.2 9480.0 1153.0 8327.0 541.0 10.0 23.8 
1.0 14.5 9065.0 1311.0 7754.0 549.0 9.6 23.4 
1.3 20.9 9220.0 1931.0 7289.0 417.0 9.6 27.0 
                
                
0.6 12.5 6398.0 801.0 5597.0 357.0 6.8 22.5 
                
1.0 9.2 8593.0 795.0 7799.0 468.0 9.1 18.3 
0.8 8.3 6421.0 530.0 5890.0 423.0 6.8 13.2 
1.1 25.6 7847.0 2009.0 5832.0 457.0 8.3 28.7 
                
1.7 18.0 7875.0 1417.0 6458.0 409.0 8.3 17.8 
1.1 12.3 7195.0 885.0 6310.0 444.0 7.6 14.3 
0.9 8.9 9049.0 801.0 8247.0 451.0 9.5 14.3 
1.0 14.6 8194.0 1197.0 6996.0 458.0 8.7 20.5 
1.1 13.9 8568.0 1188.0 7380.0 417.0 9.0 19.0 
0.9 14.4 8543.0 1234.0 7309.0 450.0 9.0 21.3 
1.0 18.6 6757.0 1259.0 5497.0 323.0 7.1 25.0 
1.4 25.1 10179.0 2559.0 7620.0 582.0 10.8 25.8 
1.2 26.7 9338.0 2497.0 6842.0 461.0 9.8 31.2 
                
0.9 6.7 7306.0 492.0 6814.0 586.0 7.9 11.2 
1.0 15.7 8842.0 1388.0 7455.0 539.0 9.4 19.9 
1.3 11.2 8458.0 949.0 7510.0 415.0 8.9 15.7 
1.4 20.2 9880.0 1997.0 7884.0 543.0 10.4 19.3 
1.0 9.4 8527.0 800.0 7727.0 443.0 9.0 13.3 
1.4 25.2 7185.0 1807.0 5377.0 333.0 7.5 28.7 
                













LegsTissue (g) LegsFat(g) Legs Lean (g) Legs BMC (g) Legs Total Mass (kg) Trunk BF% 
25729.0 4400.0 21329.0 1478.0 27.2 23.0 
20947.0 2533.0 18415.0 1315.0 22.3 24.6 
27939.0 10292.0 17647.0 1300.0 29.2 37.4 
29936.0 7894.0 22042.0 1199.0 31.1 43.0 
23311.0 5150.0 18162.0 990.0 24.3 30.4 
21248.0 1799.0 19449.0 1021.0 22.3 10.5 
19746.0 3255.0 16941.0 1132.0 20.9 32.1 
19934.0 3875.0 16059.0 1387.0 21.3 27.6 
27286.0 7694.0 19592.0 1324.0 28.6 34.7 
22812.0 4976.0 17837.0 1097.0 23.9 20.7 
17941.0 4305.0 13636.0 995.0 18.9 27.4 
19273.0 3013.0 16261.0 1073.0 20.3 20.4 
21191.0 4871.0 16319.0 1308.0 22.5 33.4 
22515.0 1712.0 20803.0 1344.0 23.9 8.9 
26567.0 6323.0 20244.0 1433.0 28.0 27.6 
27172.0 6347.0 20826.0 1605.0 28.8 30.8 
25536.0 6907.0 18629.0 1311.0 26.8 36.7 
            
            
20282.0 4563.0 15719.0 970.0 21.3 19.7 
            
23315.0 4274.0 19041.0 1307.0 24.6 20.7 
18902.0 2491.0 16411.0 1193.0 20.1 13.6 
22515.0 6463.0 16052.0 1339.0 23.9 35.0 
            
21026.0 3745.0 17281.0 1223.0 22.2 31.6 
21636.0 3104.0 18532.0 1226.0 22.9 19.0 
24532.0 3499.0 21033.0 1214.0 25.7 15.4 
24339.0 4985.0 19353.0 1328.0 25.7 25.8 
22512.0 4281.0 18231.0 1183.0 23.7 28.3 
24780.0 5276.0 19504.0 1250.0 26.0 19.7 
22908.0 5724.0 17184.0 1057.0 24.0 27.6 
30024.0 7745.0 22279.0 1540.0 31.6 40.7 
26193.0 8183.0 18011.0 1279.0 27.5 41.9 
            
19186.0 2142.0 17044.0 1506.0 20.7 14.1 
24817.0 4934.0 19884.0 1344.0 26.2 28.4 
25483.0 4002.0 21482.0 1277.0 26.8 24.7 
27618.0 5341.0 22276.0 1447.0 29.1 37.1 
24401.0 3251.0 21150.0 1235.0 25.6 20.5 
21285.0 6109.0 15175.0 954.0 22.2 44.5 
            














TrunkTissue (g) TrunkFat(g) Trunk Lean (g) Trunk BMC (g) Trunk Total Mass (kg) 
40957.0 9431.0 31526.0 1356.0 42.3 
40926.0 10086.0 30840.0 1048.0 42.0 
35089.0 13123.0 21966.0 1181.0 36.3 
50440.0 21668.0 28771.0 1232.0 51.7 
39213.0 11931.0 27282.0 805.0 40.0 
32301.0 3389.0 28912.0 840.0 33.1 
39356.0 12649.0 26707.0 954.0 40.3 
34745.0 9573.0 25172.0 915.0 35.7 
42067.0 14603.0 27464.0 1105.0 43.2 
36662.0 7598.0 29064.0 808.0 37.5 
28700.0 7871.0 20829.0 895.0 29.6 
34321.0 7007.0 27313.0 959.0 35.3 
42524.0 14213.0 28310.0 1178.0 43.7 
36709.0 3269.0 33440.0 987.0 37.7 
44487.0 12263.0 32224.0 1363.0 45.8 
40112.0 12346.0 27767.0 1394.0 41.5 
44458.0 16331.0 28127.0 1129.0 45.6 
          
          
28821.0 5679.0 23142.0 696.0 29.5 
          
37944.0 7851.0 30093.0 1297.0 39.2 
32658.0 4524.0 28135.0 696.0 33.4 
40728.0 14237.0 26491.0 1213.0 41.9 
          
41044.0 12958.0 28086.0 939.0 42.0 
34404.0 6536.0 27868.0 832.0 35.2 
35852.0 5519.0 30333.0 1048.0 36.9 
36769.0 9469.0 27301.0 1212.0 38.0 
35350.0 9996.0 25355.0 1033.0 36.4 
35143.0 6912.0 28231.0 924.0 36.1 
35173.0 9725.0 25449.0 942.0 36.1 
50538.0 20574.0 29964.0 1315.0 51.9 
45359.0 19025.0 26334.0 1211.0 46.6 
          
34140.0 4810.0 29330.0 1260.0 35.4 
41764.0 11875.0 29889.0 1151.0 42.9 
41501.0 10271.0 31230.0 964.0 42.5 
50616.0 18754.0 31862.0 1160.0 51.8 
40397.0 8289.0 32108.0 854.0 41.3 
40776.0 18131.0 22645.0 919.0 41.7 
          














Subject ID Age (years) Group Urine Specific Gravity Right ABI Left ABI 
RD1 28.0 1 1.015 1.1 1.04 
RD2 65.9 3 1.006 1.4 1.3 
RD3 27.7 1 1.018 1.05 1.19 
RD4 60.0 3 1.014 1.22 1.04 
RD5 22.5 1 1.021 1.09 1.15 
RD6 32.8 1 1.004 1.18 1.24 
RD7 72.3 3 1.007 0.99 1.07 
RD8 75.6 3 1.023 1.25 0.99 
RD9 43.2 2 1.017 1.12 1.12 
RD10 74.9 3 1.013 1.2 1.2 
RD11 26.8 1 1.022 0.97 
 RD12 22.5 1 1.022 1.13 1.12 
RD13 71.2 3 1.015 1.14 1.19 
RD14 46.0 2 1.005 1.1 0.96 
RD15 27.2 1 1.018 1.09 1.02 
RD16 49.8 2 1.016 1.29 1.17 
RD17 61.2 3 1.022 1.35 1.37 
RD18   
    RD19   
    RD20 47.3 2 1.014 1.18 1.2 
RD21   
    RD22 21.7 1 1.008 1.07 1.07 
RD23 60.3 3 1.027 1.23 1.27 
RD24 61.3 3 1.023 1.15 1.22 
RD25   
    RD26 56.1 2 1.015 1.27 1.34 
RD27 53.5 2 1.005 1.13 1.2 
RD28 46.8 2 1.018 1.09 1.09 
RD29 27.0 1 1.011 1.18 1.16 
RD30 29.0 1 1.023 1 0.97 
RD31 29.8 1 1.008 1.04 1.11 
RD32 27.2 1 1.012 1.03 1.14 
RD33 57.2 2 
 
1.25 1.19 
RD34 48.8 2 1.006 1.19 1.2 
RD35   
    RD36 71.1 3 1.012 1.23 1.27 
RD37 51.6 2 1.02 1.15 1.15 
RD38 40.8 2 1.005 1.06 1.06 
RD39 44.0 2 1.008 1.19 1.19 
RD40 48.9 2 1.006 1.12 1.12 
RD41 57.0 2 1.019 1.28 1.26 
RD42   
 
1.023 1.2 1.02 




























































RD2 3 100 135 86 105 84 12 8 60 29 22 146 127 
RD3 1 99 121 69 85 51 1 -2 51 4 -8 201 102 
RD4 3 100 127 70 87 71 5 4 67 13 10 162 111 
RD5 1 92 137 72 86 16 -7 -8 70 -19 -21 166 110 
RD6 1 92 111 63 76 48 -1 -5 45 -3 -17 174 92 
RD07 3 95 139 82 106 75 12 13 81 27 30 128 127 
RD8 3 98 140 81 102 106 21 14 57 41 32 129 133 
RD9 2 100 122 74 90 75 7 3 58 18 10 167 111 
RD10 3 100 111 71 83 60 4 0 46 14 0 157 99 
RD11 1 91 113 74 85 41 -1 -2 72 -5 -7 151 97 
RD12 1 92 125 81 95 43 -1 -2 60 -2 -9 152 107 
RD13 3 100 133 86 103 78 9 7 65 25 20 140 123 
RD14 2 98 120 80 93 61 3 1 61 12 6 159 108 
RD15 1 95 125 72 91 64 3 -2 46 9 -5 196 110 
RD16 2 92 108 71 85 81 8 4 50 28 15 152 102 
RD17 3 94 117 81 93 84 9 5 48 30 17 158 112 
RD20 2 95 110 68 83 68 5 1 49 16 4 186 100 
RD22 1 90 134 69 88 37 -4 -5 66 -10 -14 210 108 
RD23 3 98 106 64 74 52 3 -1 46 10 -4 145 91 
RD24 3 100 118 80 95 83 6 2 52 20 9 192 112 
RD26 2 100 127 71 90 71 5 0 47 12 -1 192 114 
RD27 2 100 116 71 88 74 9 4 49 25 12 154 107 
RD28 2 100 120 72 90 79 9 3 50 23 10 168 111 
RD29 1 99 132 78 95 62 5 1 55 13 4 152 115 
RD30 1 100 120 72 86 37 -2 -1 77 -6 -5 153 100 
RD31 1 100 113 69 82 47 0 -3 56 -1 -10 176 96 
RD32 1 97 124 69 85 42 0 -3 58 -1 -9 174 103 
RD33 2 100 120 78 93 73 5 1 50 14 2 202 111 
RD34 2 92 108 73 84 72 5 0 42 18 2 176 100 
RD36 3 100 118 73 88 82 11 5 50 28 16 150 111 
RD37 2 100 124 69 88 63 2 3 78 6 7 167 106 
RD38 2 100 127 85 98 65 4 2 63 14 8 161 115 
RD39 2 97 131 85 102 79 9 5 57 24 16 158 122 
RD40 2 100 121 67 84 61 5 2 59 12 5 167 106 
RD41 2 100 132 82 99 80 10 8 66 26 22 146 122 





































87 105 140 100 145 85 106 73 10 7 
70 85 104 100 128 70 88 48 0 2 
71 87 115 99 131 67 86 9999 4 8 
72 86 81 98 136 61 79 25 -5 -1 
63 76 97 100 122 62 79 40 -1 -1 
84 106 137 100 138 68 87 9999 0 6 
82 102 169 97 140 80 103 80 9 14 
75 90 122 100 130 67 86 63 4 4 
71 83 116 100 125 71 86 54 3 -1 
75 85 95 100 103 61 75 55 1 5 
82 95 98 99 143 89 106 44 -1 2 
87 103 133 100 133 82 99 68 4 5 
81 93 114 100 132 76 94 58 3 4 
73 91 110 98 130 64 81 9999 -5 -1 
72 85 138 93 113 64 80 63 8 4 
81 93 143 99 132 71 89 9999 3 6 
69 83 119 94 121 69 86 59 4 0 
71 88 90 100 143 62 83 28 -6 -2 
64 74 111 97 105 67 78 50 2 0 
81 95 125 100 124 75 92 74 2 2 
72 90 114 97 124 66 82 53 3 -2 
72 88 133 100 123 67 84 55 4 1 
73 90 129 100 129 65 83 47 1 -1 
79 95 116 100 145 79 98 45 -1 -1 
73 86 94 98 133 60 78 29 -4 2 
70 82 99 100 121 62 78 37 -3 -1 
70 85 99 97 126 64 80 40 0 0 
78 93 117 97 121 69 86 59 -1 -3 
73 84 122 98 108 56 74 55 10 8 
73 88 140 98 122 75 91 69 6 3 
71 88 106 100 124 70 86 9999 -1 2 
85 98 116 100 137 74 92 9999 2 5 
86 102 132 100 133 79 97 68 8 8 
68 84 114 95 130 69 87 56 2 -1 
83 99 135 96 128 77 95 9999 5 8 









































66 22 17 149 131 87 106 128 100 143 92 
91 -1 7 146 105 74 88 99 97 118 71 
90 9 16 165 112 69 86 109 98 120 68 
91 -11 -3 162 106 63 79 89 94 126 68 
74 -3 -4 181 100 63 79 97 98 110 62 
100 1 13 140 110 70 87 101 100 128 80 
91 22 30 143 125 83 103 129 100 136 81 
75 9 10 177 111 69 86 110 95 118 75 
52 9 -2 165 108 72 86 110 98 127 79 
98 4 16 172 89 62 75 105 93 106 72 
91 -3 5 161 123 92 106 97 100 118 75 
81 13 16 147 117 83 99 115 100 129 77 
83 8 11 173 114 78 94 109 98 126 84 
94 -12 -4 182 105 66 81 88 91 141 77 
60 21 13 9999 101 65 80 126 95 111 68 
87 8 14 162 113 73 89 109 92 118 78 
53 11 0 174 106 70 86 112 94 108 71 
94 -14 -5 160 111 66 83 86 100 130 75 
58 10 2 143 92 68 78 111 100 108 64 
74 5 4 196 112 76 92 105 100 114 80 
47 7 -7 159 103 66 82 107 99 131 77 
60 10 3 159 105 68 84 111 100 119 76 
65 3 -2 172 106 66 83 103 95 116 64 
76 -3 -2 163 119 81 98 97 98 129 68 
107 -10 5 146 103 62 78 90 99 117 64 
93 -10 -2 158 97 64 78 90 100 111 66 
77 -1 0 162 102 65 80 99 97 124 71 
61 -2 -8 209 107 70 86 98 95 120 78 
67 26 22 9999 95 57 74 135 98 110 72 
57 18 10 154 110 76 91 122 94 123 76 
91 -2 6 159 103 72 86 98 100 113 66 
90 4 12 159 114 76 92 104 95 138 88 
75 20 20 139 119 80 97 125 99 120 83 
62 5 -1 182 111 70 87 105 100 123 68 
89 15 22 139 113 80 95 118 98 136 85 




































110 76 9 6 63 24 18 146 132 93 
86 63 5 1 48 15 2 172 104 71 
84 68 4 2 64 10 5 187 106 69 
82 22 -8 -11 60 -21 -29 203 105 68 
76 55 2 -3 43 6 -10 168 93 62 
96 65 6 6 75 18 18 140 115 81 
102 104 21 15 58 42 34 135 132 82 
89 81 8 4 53 23 12 162 110 76 
93 69 7 1 43 19 4 155 115 80 
82 31 -3 -3 75 -16 -16 147 92 73 
87 51 0 -4 46 -2 -16 149 100 76 
97 82 11 8 63 28 22 143 119 79 
98 60 3 1 61 10 4 173 114 85 
97 53 0 -5 50 -1 -12 197 119 78 
82 73 6 9999 40 19 9999 180 102 68 
92 87 10 5 51 30 18 154 113 78 
84 62 3 0 48 13 0 153 96 72 
92 55 -1 -5 53 -3 -13 205 111 76 
77 61 2 -2 47 7 -6 201 96 64 
93 87 6 4 62 22 16 181 109 81 
96 86 13 4 41 28 12 161 123 77 
92 68 6 2 52 19 8 154 108 77 
79 52 2 -3 47 5 -8 9999 98 65 
90 67 6 1 50 14 2 185 113 69 
80 46 1 0 72 2 0 161 97 65 
80 45 0 -2 65 -1 -6 172 94 67 
87 44 -2 -5 55 -5 -15 218 105 72 
93 75 6 2 51 17 5 190 111 79 
84 80 7 2 44 24 9 147 101 72 
93 86 12 5 45 30 16 153 117 77 
81 64 1 0 70 4 1 186 98 67 
105 76 6 5 66 17 13 172 126 89 
98 84 9 5 56 28 19 155 114 84 
86 61 5 1 53 13 2 183 108 69 
103 81 8 8 73 21 20 149 125 86 










































110 131 100 151 96 116 86 14 9 57 31 
86 117 92 121 65 84 65 7 2 50 18 
84 111 100 115 72 85 60 3 0 57 9 
82 79 98 123 66 78 9999 -6 -8 58 -17 
76 106 100 104 61 73 49 -2 -6 43 -6 
96 122 100 150 88 109 74 12 9 66 25 
102 172 98 143 84 108 94 22 14 52 41 
89 130 91 131 82 98 78 8 4 52 22 
93 124 100 128 79 94 81 10 3 41 26 
82 84 100 104 76 84 39 -1 -1 73 -7 
87 98 95 115 75 86 54 0 -2 51 2 
97 139 99 128 85 101 84 10 8 62 30 
98 111 96 121 84 97 66 4 2 58 16 
97 99 100 134 74 92 51 1 -4 48 2 
82 123 91 115 73 86 68 5 0 41 16 
92 143 100 121 82 96 87 11 6 50 32 
84 115 97 113 75 87 74 5 1 45 19 
92 97 97 130 79 94 51 0 -4 52 -1 
77 108 100 104 64 77 60 3 -1 47 11 
93 128 100 117 80 94 88 9 6 58 29 
96 140 95 124 76 91 81 15 7 44 37 
92 124 100 117 78 92 64 4 1 50 16 
79 105 100 115 68 82 55 1 -3 45 4 
90 117 98 128 78 92 60 4 -1 48 11 
80 102 97 117 74 87 44 0 -1 62 0 
80 99 100 105 61 73 42 0 -3 56 -2 
87 95 99 121 71 86 48 -3 -6 50 -8 
93 121 100 124 78 92 62 4 0 47 13 
84 132 99 110 72 85 81 7 2 43 24 
93 143 100 130 83 99 92 14 6 43 33 
81 104 100 117 69 85 68 3 0 59 8 
105 120 100 145 94 110 71 6 3 60 17 
98 139 98 131 85 102 83 10 6 59 26 
86 114 100 118 62 80 56 3 0 53 9 
103 127 100 127 79 94 74 9 6 62 23 
















PostCon_C_AGPH_HR75 PostCon_C_T1R PostCon_C_SP PostCon_C_DP PostCon_C_MEANP PostCon_C_AI 
23 141 143 97 116 146 
6 175 105 66 84 122 
1 170 102 73 85 110 
-25 159 99 66 78 83 
-21 188 87 61 73 94 
20 134 136 89 109 133 
30 134 140 86 108 170 
10 162 121 83 98 128 
10 150 118 80 94 136 
-8 147 92 77 84 93 
-10 154 99 76 86 102 
24 143 121 86 101 143 
8 162 111 85 97 118 
-11 186 112 75 92 102 
-1 189 105 74 86 119 
20 147 116 83 96 147 
4 165 103 75 87 123 
-12 164 109 80 94 99 
-2 184 93 64 77 113 
21 170 112 81 94 140 
23 180 116 76 91 159 
4 164 106 79 92 119 
-10 155 97 69 82 104 
-2 167 112 78 92 112 
-6 159 100 75 87 100 
-11 170 88 62 73 98 
-21 198 103 72 86 92 
-1 179 111 78 92 115 
9 147 101 72 85 132 
17 152 125 84 99 149 
0 188 104 70 85 108 
10 168 132 95 110 121 
18 158 123 86 102 136 
-1 161 100 63 80 110 
17 144 116 79 94 131 













ct Group BodySurfaceArea Dubois Formula (m2) 
PreEx_SV 
(ml) PreEX-SV_Index (ml/beat)/m2) 
PreEx_EDV 
(ml) 
2 3 1.92 123 64 188 
3 1 1.92 111 58 193 
4 3 2.23 110 49 188 
5 1 1.97 70 35 115 
6 1 1.82 93 51 177 
7 3 1.79 97 54 141 
9 2 2.07 79 38 137 
10 3 1.96 95 49 132 
11 1 1.66 59 35 98 
12 1 1.81 98 54 174 
14 2 2.01 76 38 111 
15 1 2.17 89 41 143 
16 2 2.05 102 50 173 
17 3 2.01 94 47 152 
20 2 1.70 76 45 135 
22 1 1.97 63 32 109 
23 3 1.86 86 46 152 
24 3 2.01 102 51 199 
26 2 1.87 102 54 179 
27 2 1.88 87 46 158 
28 2 1.95 117 60 185 
29 1 1.91 90 47 158 
30 1 1.85 93 50 144 
31 1 1.92 88 46 146 
32 1 1.90 81 43 137 
34 2 2.04 76 37 161 
36 3 1.89 62 33 100 
37 2 2.09 83 40 137 
38 2 2.00 124 62 179 
40 2 1.98 117 59 187 
41 2 1.89 81 43 131 






























98 65 34 59 7.2 3.8 65 
101 81 42 51 5.7 3.0 58 
84 78 35 67 7.3 3.3 59 
58 46 23 66 4.6 2.3 61 
97 84 46 47 4.4 2.4 52 
79 44 24 68 6.6 3.7 69 
66 57 27 56 4.4 2.1 59 
67 37 19 46 4.4 2.2 72 
59 39 24 76 4.5 2.7 60 
96 77 43 48 4.7 2.6 56 
55 35 17 59 4.5 2.2 68 
66 54 25 45 4.0 1.9 62 
85 71 35 43 4.4 2.1 59 
76 59 29 49 4.6 2.3 61 
79 59 35 48 3.7 2.2 57 
55 46 23 63 3.9 2.0 58 
82 65 35 46 4.0 2.1 57 
99 98 49 56 5.7 2.8 51 
96 77 41 47 4.8 2.6 57 
84 71 38 48 4.2 2.2 55 
95 68 35 49 5.7 2.9 63 
83 68 36 56 5.0 2.6 57 
78 50 27 64 6.0 3.2 65 
76 59 31 60 5.3 2.7 59 
72 55 29 56 4.6 2.4 60 
79 86 42 45 3.4 1.7 47 
53 38 20 52 3.2 1.7 62 
65 53 26 79 6.6 3.2 61 
89 55 28 60 7.4 3.7 69 
94 71 36 57 6.7 3.4 63 
69 50 26 62 5.0 2.7 64 






























37 143 75 65 9.3 4.8 69 
31 84 44 89 7.5 3.9 58 
32 133 60 85 11.3 5.1 68 
32 74 38 77 5.7 2.9 62 
28 83 46 70 5.8 3.2 56 
39 97 54 98 9.5 5.3 71 
31 100 48 77 7.7 3.7 60 
41 80 41 52 4.1 2.1 67 
32 76 46 94 7.1 4.3 67 
29 89 49 94 8.4 4.6 58 
39 70 35 78 5.4 2.7 66 
34 94 43 92 8.7 4.0 61 
32 125 61 56 7.0 3.4 69 
33 104 51 83 8.6 4.3 61 
30 78 46 56 4.3 2.6 59 
31 58 30 93 5.4 2.8 60 
30 87 47 51 4.4 2.4 58 
27 70 35 74 5.2 2.6 59 
30 102 54 50 5.1 2.7 60 
29 83 44 60 5.0 2.7 55 
35 99 51 61 6.0 3.1 61 
30 72 38 67 4.8 2.5 54 
36 91 49 108 9.9 5.3 68 
32 78 40 88 6.8 3.6 60 
32 93 49 77 7.1 3.8 58 
24 80 39 69 5.5 2.7 50 
34 61 32 53 3.2 1.7 58 
33 82 39 86 7.0 3.4 61 
39 96 48 93 9.0 4.5 64 
35 134 68 60 8.0 4.1 75 
36 92 49 87 8.0 4.2 65 






























40 147 76 60 8.8 4.6 72 
31 76 40 47 3.6 1.9 58 
39 88 40 56 4.9 2.2 60 
34 70 36 66 4.6 2.3 59 
30 85 47 46 3.9 2.1 53 
40 104 58 72 7.5 4.2 62 
32 96 46 54 5.2 2.5 68 
37 90 46 42 3.8 1.9 67 
37 70 42 69 4.8 2.9 56 
31 101 56 49 4.9 2.7 65 
36 84 42 65 5.5 2.7 63 
33 87 40 45 3.9 1.8 58 
50 114 55 39 4.4 2.2 65 
33 87 43 50 4.4 2.2 55 
31 118 70 47 5.6 3.3 62 
32 68 35 51 3.5 1.8 62 
31 74 40 48 3.6 1.9 54 
31 99 49 59 5.8 2.9 60 
33 114 61 41 4.7 2.5 54 
29 80 42 49 3.9 2.1 57 
33 106 54 49 5.2 2.7 66 
28 80 42 52 4.1 2.2 50 
38 76 41 62 4.7 2.5 58 
32 89 46 60 5.3 2.8 52 
31 86 45 62 5.3 2.8 53 
26 93 45 42 3.9 1.9 61 
30 63 33 45 2.9 1.5 61 
33 87 42 68 5.9 2.8 57 
35 114 57 65 7.4 3.7 64 
37 119 60 52 6.2 3.1 70 
36 86 46 70 6.0 3.2 65 


































42 123 64 59 7.3 3.8 66 37 
31 90 47 47 4.2 2.2 57 30 
33 122 55 53 6.5 2.9 67 38 
31 103 52 61 6.3 3.2 63 35 
28 87 48 46 4.0 2.2 57 30 
34 93 52 69 6.4 3.6 61 33 
38 98 47 52 5.1 2.5 61 33 
37 88 45 40 3.5 1.8 64 35 
29 80 48 71 5.7 3.4 63 34 
36 86 47 49 4.2 2.3 61 33 
35 85 42 56 4.8 2.4 62 35 
32 93 43 49 4.6 2.1 57 30 
36 114 56 38 4.3 2.1 69 39 
29 100 50 47 4.7 2.3 60 33 
34 118 69 45 5.3 3.1 62 34 
34 64 32 51 3.2 1.7 59 31 
29 62 33 44 2.7 1.5 52 27 
32 88 44 57 5.0 2.5 52 27 
28 102 55 40 4.1 2.2 102 33 
30 84 45 44 3.7 2.0 67 37 
37 102 52 46 4.7 2.4 60 32 
26 87 46 49 4.3 2.2 56 29 
31 74 40 59 4.4 2.4 57 30 
27 96 50 56 5.4 2.8 57 31 
28 86 45 53 4.6 2.4 59 32 
33 85 42 44 3.7 1.8 59 31 
33 74 39 41 3.0 1.6 73 42 
30 77 37 54 4.2 2.0 56 29 
35 113 56 65 7.3 3.7 61 33 
40 128 64 50 6.4 3.2 71 41 
36 89 47 60 5.3 2.8 64 36 















Subject EX (FBF) 1 2 3 4 5 6 Avg 
2 Pre 3.5 3.87 4.51 3.2 4.17 3.69 3.82 
 
Post 4.23 3.57 3.25 3.62 3.47 2.96 3.52 
3 Pre 2.79 2.48 2.7 2.52 2.3 1.03 2.30 
 
Post 6.64 6.38 6.29 6.18 6.01 6.35 6.31 
4 Pre  3.28 3.36 3.38 2.7 3.52 2.45 3.12 
 
Post 6.56 6.27 6.64 6.72 8.37 6.72 6.88 
5 Pre 2.64 2.72 3.12 3.24 3.83 3.54 3.18 
 
Post 3.92 4.41 4.81 4.97 4.85 5.43 4.73 
6 Pre 3.6 3.04 3.36 2.87 3.42 2.96 3.21 
 
Post 5.95 5.61 6.16 7.38 7.18 6.16 6.41 
7 Pre 2.35 1.68 1.69 1.6 2.08 1.9 1.88 
 
Post 4.93 4.17 4.41 4.19 4.32 5.01 4.51 
8 Pre  3.85 3.45 3.32 2.33 3.34 3.15 3.24 
 
Post 7.36 7.44 7.12 7.67 7.02 7.12 7.29 
9 Pre 3.73 3.28 4.03 4.57 4.33 3.96 3.98 
 
Post 8.07 7.14 6.62 7.71 7.07 6.94 7.26 
10 Pre 2.65 2.46 2.63 2.58 2.5 2.52 2.56 
 
Post 4.43 5.17 4.46 5.34 5.14 5.2 4.96 
11 Pre 1.35 1.34 1.19 1.82 2.38 1.47 1.59 
 
Post 7.06 5.62 4.33 4.91 4.98 5.68 5.43 
12 Pre  0.48 1.9 1.47 1.29 1.16 1.31 1.27 
 
Post 4.71 4.97 4.76 4.68 5.1 4.79 4.84 
13 Pre 2.88 1.98 2.24 2.09 2.23 2.3 2.29 
 
Post 5.57 4.85 5 5.82 6 5.58 5.47 




Post 4.01 3.64 3.46 4.03 4.08 2.48 3.62 
15 Pre 1.89 1.94 1.94 1.9 2.31 2.15 2.02 
 
Post 5.95 6.96 7.09 6.92 6.88 6.89 6.78 
16 Pre  1.81 1.34 1.64 1.6 2.9 1.9 1.87 
 
Post 4.16 3.65 4.12 4.98 4.4 4.46 4.30 
17 Pre 2.45 2 2.24 2.24 2.22 2.23 2.23 
 
Post 8.14 6.24 5.08 6.69 5.92 6.27 6.39 
18 Pre             #DIV/0! 
  Post             #DIV/0! 
19 Pre             #DIV/0! 
  Post             #DIV/0! 
20 Pre  2.33 1.85 1.88 1.87 1.6 2.73 2.04 
 
Post 3.1 2.78 2.46 2.81 3.52 2.82 2.92 
21 Pre             #DIV/0! 
  Post             #DIV/0! 
22 Pre 2.13 2.26 2.73 2.52 2.26 2.53 2.41 
 
Post 5.79 5.68 6.15 6.52 4.87 4.33 5.56 
23 Pre 1.86 1.52 2.02 2.08 2.18 1.29 1.83 
 
Post 1.49 2.35 1.87 1.94 2.1 1.84 1.93 
24 Pre  0.82 0.92 1.52 1.09 1.58 0.91 1.14 
 
Post 2.43 3.45 2.83 2.99 3.16 3.06 2.99 
25 Pre             #DIV/0! 
  Post             #DIV/0! 
26 Pre 2.89 3.1 3.04 2.68 2.97 3 2.95 
 
Post 2.36 3.04 2.81 2.43 2.44 2.41 2.58 
27 Pre 3.52 3.49 3.42 3.32 2.64 3.62 3.34 
 
Post 4.97 4.94 4.95 5.33 4.8 5.55 5.09 
28 Pre  1.81 2.6 2.01 1.96 2.28 2.22 2.15 
 
Post 5.61 5.67 5.65 5.38 5.61 5.12 5.51 
29 Pre 3.82 3.56 3.75 3.73 3.4 3.26 3.59 
 
Post 5.46 5 5.33 4.79 4.98 4.79 5.06 
30 Pre 2.89 2.65 3.26 2.78 3 3.2 2.96 
 
Post 6.18 6.76 5.75 5.76 5.65 6.27 6.06 
31 Pre 2.73 3.26 3.38 3.06 3.17 3.62 3.20 
 
Post 5.92 6.76 6.52 6.96 6.8 6.96 6.65 




Post 6.27 6.43 6.46 6.81 6.55 7.01 6.59 
33 Pre 2.87 1.92 0.72 
 
1.78 2.34 1.93 
 
Post 1.05 2.14 1.67 2.13 1.93 1.3 1.70 
34 Pre 2.03 1.94 1.11 2.01 1.43 1.56 1.68 
 
Post 4.21 4.08 3.94 3.31 3.58 3.46 3.76 
35 Pre             #DIV/0! 
  Post             #DIV/0! 
36 Pre  1.93 2.53 2.19 2.06 2.72 2.6 2.34 
 
Post 2.16 2.52 2.9 2.43 2.59 2.92 2.59 
37 Pre 6.11 5.36 6.33 6.42 6.68 6.54 6.24 
 
Post 5.61 5.75 6.68 6.04 6.22 7.01 6.22 
38 Pre 2.92 2.92 3.45 3.5 3.25 3.27 3.22 
 
Post 7.04 6.24 6.27 6.6 7.19 7.6 6.82 
39 Pre 2.57 2.96 2.8 2.57 2.39 2.75 2.67 
 
Post 5.54 5.34 5.7 4.62 5.58 5.73 5.42 
40 Pre  11.45 11.92 13.06 13.65 13.56 13.57 12.87 
 
Post 9.41 10.32 10.91 10.13 10.24 11.22 10.37 
41 Pre 3.82 4.17 4.02 4.28 5.09 3.84 4.20 
 
Post 2.77 3.04 3.36 3 2.84 3.56 3.10 
42 Pre             #DIV/0! 
  Post             #DIV/0! 
43 Pre 2.6 2.17 2.46 2.02 2.55 2.23 2.34 
 





















CON (FBF) 1 2 3 4 5 6 Avg 
Pre 3.08 3.16 3.64 3.84 3.85 4.2 3.63 
Post 2.92 2.82 2.65 2.71 2.35 2.24 2.62 
Pre 4.6 4.33 4.09 4.36 3.88 4.32 4.26 
Post 3.32 2.49 3.18 3.46 2.26 2.53 2.87 
Pre  2.19 3.4 4.13 3.26 2.41 3.04 3.07 
Post 3.52 4.07 2.05 2.45 2.24 1.39 2.62 
Pre 3.56 4.09 3.76 3.31 3.52 4.28 3.75 
Post 3.16 3.27 2.7 2.69 2.31 3.32 2.91 
Pre 2.96 2.27 2.58 1.93 2.07 2.26 2.35 
Post 2.08 2.16 2.02 2.59 2.25 2.71 2.30 
Pre 2.83 1.8 0.84 1.29 1.97 1.71 1.74 
Post 1.85 1.52 1.67 1.7 1.87 1.53 1.69 
Pre  2.11 2.6 2.8 2.06 2.68 2.55 2.47 
Post 2.59 2.15 1.87 2.35 2.54 2.38 2.31 
Pre 4.04 3.62 2.69 3.99 3.4 3.41 3.53 
Post 2.63 2.29 1.61 2.56 2.34 1.8 2.21 
Pre 3.34 3.22 2.65 3.16 3.3 2.5 3.03 
Post 2.4 2.64 2.89 2.31 1.77 2.11 2.35 
Pre 1.39 1.48 1.11 1.51 1.27 2.54 1.55 
Post 1.06 0.84 1.5 1.64 1.17 0.72 1.16 
Pre  1.54 0.98 1 0.61 1.33 1.51 1.16 
Post 2.54 1.86 1.2 1.13 2.24 2.1 1.85 
Pre 3.2 2.97 3.24 2.61 2.83 3.54 3.07 
Post 2.82 2.7 2.28 2.41 2.41 2.37 2.50 
Pre 2.57 1.96 1.83 1.78 2.24 1.59 2.00 
Post 1.71 0.86 1.66 0.85 0.87 1.12 1.18 
Pre 3.1 2.66 2.14 2.32 2.48 2.87 2.60 
Post 1.85 2.02 1.94 2.37 1.94 2.53 2.11 
Pre  3.1 2.71 3.28 2.85 2.3 2.48 2.79 
Post 2.61 2.28 2.24 2.05 2.49 2.92 2.43 
Pre 1.8 1.97 2.1 2.59 2.28 3.26 2.33 
Post 2.32 1.86 1.31 1.52 2.1 2.05 1.86 
Pre             #DIV/0! 
Post             #DIV/0! 
Pre             #DIV/0! 
Post             #DIV/0! 
Pre  1.52 2.19 1.7 2.2 1.46 1.29 1.73 
Post 1.9 1.74 0.96 1.69 1.99 1.19 1.58 
Pre             #DIV/0! 
Post             #DIV/0! 
Pre 1.85 1.75 1.35 1.62 2.49 1.68 1.79 
Post 2.3 1.77 2.02 1.62 2.04 2.07 1.97 
Pre 1.4 1.41 1.65 1.7 1.47 1.33 1.49 
Post 1.33 1.55 0.93 1.68 1.87 1.67 1.51 
Pre  2.07 1.86 1.57 1.75 2.14 2.31 1.95 
Post 1 1.92 1.68 1.44 1.21 1.24 1.42 
Pre             #DIV/0! 
Post             #DIV/0! 
Pre 3.41 3.12 2.66 2.83 3.57 3.12 3.12 
Post 2.11 2.3 2.44 2.06 1.59 2.11 2.10 
Pre 2.14 2.5 3.09 2.57 2.24 3.11 2.61 
Post 3.1 2.87 2.75 1.76 1.48 2.41 2.40 
Pre  2.28 3.04 3.32 2.94 2.64 2.22 2.74 
Post 3.29 2.04 2.36 3.02 2.54 2.55 2.63 
Pre 4.25 4.15 3.66 4.18 3.32 3.57 3.86 
Post 3.44 3.52 2.78 3.06 3.27 3.03 3.18 
Pre 3.52 3.12 2.87 3.72 3.2 2.7 3.19 
Post 1.8 1.91 2.58 2.17 1.86 2.15 2.08 
Pre 2.48 4.19 2.71 3.34 2.53 3.96 3.20 
Post 3.26 3.36 2.9 3.57 3.24 3.36 3.28 
Pre  5.33 6.27 5.64 5.85 5.55 5.26 5.65 
Post 1.83 2.75 2.08 2.17 1.97 2.58 2.23 
Pre 2.15 2.19 1.57 0.62 2.51 2.61 1.94 
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Post 1.92 1.4 4.31 1.9 1.93 1.77 2.21 
Pre 1.49 1.3 1.26 1.28 1.2 1.03 1.26 
Post 2.83 1.71 2.17 1.4 1.23 1.77 1.85 
Pre             #DIV/0! 
Post             #DIV/0! 
Pre  2.22 1.55 1.57 1.93 1.57 2.1 1.82 
Post 1.65 1.66 2.28 1.31 1.62 1.71 1.71 
Pre 3.22 2.94 3.24 3.46 3.98 3.77 3.44 
Post 3.08 3.02 3 2.75 2.75 2.75 2.89 
Pre 4.39 3.78 3.79 4.01 3.6 4.05 3.94 
Post 3.85 3.1 2.57 3.2 3.38 3.15 3.21 
Pre 3.38 2.8 2.46 2.34 2.07 2.22 2.55 
Post 3.56 3 3.64 3.34 2.94 2.56 3.17 
Pre  7.93 8.87 5.68 7.39 7.8 7.71 7.56 
Post 3.68 3.4 3.32 2.66 3.55 4.62 3.54 
Pre 2.45 2.46 2.08 2.71 2.78 3.31 2.63 
Post 2.09 2.63 2.75 2.6 2.31 2.38 2.46 
Pre             #DIV/0! 
Post             #DIV/0! 
Pre 2.78 2.78 2.55 2.46 3.38 2.65 2.77 





















Subject Group Pre_EX_FBF MAP Pre_EX_FBF_VC Pre_CON_FBF MAP 
2 3 3.82 105 36.41 3.63 110 
3 1 2.30 85 27.10 4.26 86 
4 3 3.12 87 35.80 3.07 84 
5 1 3.18 86 37.00 3.75 82 
6 1 3.21 76 42.21 2.35 76 
7 3 1.88 106 17.77 1.74 96 
8 3 3.24 102 31.76 2.47 102 
9 2 3.98 90 44.26 3.53 89 
10 3 2.56 83 30.80 3.03 93 
11 1 1.59 85 18.73 1.55 82 
12 1 1.27 95 13.35 1.16 87 
13 3 2.29 103 22.20 3.07 97 
14 2 1.72 93 18.49 2.00 98 
15 1 2.02 91 22.22 2.60 97 
16 2 1.87 85 21.94 2.79 82 
17 3 2.23 93 23.98 2.33 92 
20 2 2.04 83 24.62 1.73 84 
22 1 2.41 88 27.33 1.79 92 
23 3 1.83 74 24.66 1.49 77 
24 3 1.14 95 12.00 1.95 93 
26 2 2.95 90 32.74 3.12 96 
27 2 3.34 88 37.90 2.61 92 
28 2 2.15 90 23.85 2.74 79 
29 1 3.59 95 37.75 3.86 90 
30 1 2.96 86 34.46 3.19 80 
31 1 3.20 82 39.07 3.20 80 
32 1 2.45 85 28.78 5.65 87 
33 2 1.93 93 20.71 1.94 93 
34 2 1.68 84 20.00 1.26 84 
36 3 2.34 88 26.57 1.82 93 
37 2 6.24 88 70.91 3.44 81 
38 2 3.22 98 32.84 3.94 105 
39 2 2.67 102 26.21 2.55 98 
40 2 12.87 84 153.19 7.56 86 
41 2 4.20 99 42.46 2.63 103 
















Pre_CON_FBF_VC Post_EX_FBF MAP Post_EX_FBF_VC Post_CON_FBF MAP 
Post_CON_FBF_
VC 
32.98 3.52 106 33.18 2.62 116 22.54 
49.57 6.31 88 71.69 2.87 84 34.21 
36.57 6.88 86 80.00 2.62 85 30.82 
45.77 4.73 79 59.89 2.91 78 37.29 
30.86 6.41 79 81.10 2.30 73 31.53 
18.13 4.51 87 51.78 1.69 109 15.50 
24.18 7.29 103 70.76 2.31 108 21.42 
39.61 7.26 86 84.40 2.21 98 22.50 
32.56 4.96 86 57.64 2.35 84 28.02 
18.90 5.43 75 72.40 1.16 94 12.29 
13.35 4.84 106 45.61 1.85 86 21.45 
31.60 5.47 99 55.25 2.50 101 24.74 
20.36 3.62 94 38.48 1.18 97 12.15 
26.75 6.78 81 83.72 2.11 92 22.92 
33.98 4.30 80 53.69 2.43 86 28.28 
25.36 6.39 89 71.80 1.86 96 19.38 
20.56 2.92 86 33.90 1.58 87 18.14 
19.46 5.56 83 66.95 1.97 94 20.96 
19.39 1.93 78 24.76 1.51 77 19.55 
20.97 2.99 92 32.46 1.42 94 15.05 
32.48 2.58 82 31.48 2.10 91 23.10 
28.35 5.09 84 60.60 2.40 92 26.03 
34.68 5.51 83 66.35 2.63 82 32.11 
42.83 5.06 98 51.62 3.18 92 34.60 
39.85 6.06 78 77.71 2.08 87 23.89 
40.02 6.65 78 85.30 3.28 73 44.95 
64.94 6.59 80 82.35 2.23 86 25.93 
20.88 1.70 86 19.81 2.21 92 23.97 
15.00 3.76 74 50.86 1.85 85 21.78 
19.61 2.59 91 28.42 1.71 99 17.22 
42.41 6.22 86 72.31 2.89 85 34.02 
37.49 6.82 92 74.17 3.21 110 29.17 
25.97 5.42 97 55.86 3.17 102 31.11 
87.95 10.37 87 119.21 3.54 80 44.23 
25.55 3.10 95 32.58 2.46 94 26.17 






























1 8.9 6.1 7.4 7.2 7.2 7.2 7.7 7.1 
3 10 8.7 8.8 9.4 8.8 8.7 9.1 8.3 
1 8.5 6.8 7.5 8.5 7.3 6.2 6.9 6.5 
3 7.4 8.1 7 8.3 7.1 7.2 7.4 7.9 
1 7.8 5.7 8.4 5.5 7.4 6.1 8.9 5.7 
1 7.6 5.4 7 5.5 7.2 4.5 8.1 5.7 
3 8.3 10.6 7.9 11.8 8.6 9.4 9.3 8 
3 4.9 7.8 7.5 8 6.2 7.9 8.4 8.1 
2 7.2 7.3 6.8 6.7 8.4 7.1 8.4 7.6 
3 7.1 6.1 6.5 5.5 9.5 7.2 8.5 5.4 
1 7.8 6.7 6.4 6.4 7.1 6.1 7 5.3 
1 7.8 6 6.5 7.5 7.6 5.8 7 5.6 
3 8.6 10.7 9 10 8 10 8.5 10.4 
2 7.8 7.1 9.6 8.3 7.5 7.3 7.6 7.2 
1 8.1 6 8 5.8 7.3 5.3 9.2 5.6 
2 7 5.2 6.3 5.4 6.9 5.5 6.7 5.8 
3 8.4 7.5 7.8 7.3 9.8 8.4 8.3 6.4 
                  
                  
2 7.3 5.2 8.6 5.7 7.1 6.1 6.7 6.2 
                  
1 7.9 6.6 7.2 7.4 9.4 6.3 8.9 5.9 
3 9.7 6.9 8.6 8.3 7.6 8 8.1 7.3 
3 9 8.2 10.7 7.5 10.5 8.3 9.1 8.9 
                  
2 6.3 6 7 5.9 6.6 6.3 7.6 6.8 
2 6.9 6.4 6.5 5.6 8.7 6.1 6.8 8.1 
2 6.5 6.4 6.7 6.5 7.6 5.9 8.9 6.6 
1 7.4 5.8 7.9 5.5 6.9 5.5 6.6 5.8 
1 7.6 6.6 6.2 7.8 6.3 6.8 6.9 6.5 
1 6.5 4.5 6.3 5.4 6.3 5.4 6.2 5 
1 7.4 5.4 6.6 5.5 9.3 5.7 10.4 5.5 
2 7.7 7 7.3 6.7 7.9 7.1 8.9 6.9 
2 7.4 5.8 9.5 5.6 7.5 5 8.6 5.3 
                  
3 8 8.1 8 7 8.3 7.9 8.6 7.8 
2.0 7.4 6.8 6.0 8.7 7.7 7.1 8.3 6.7 
2 7.4 7.2 6.6 7.1 8.8 9.2 8.3 7.1 
2 9.5 7.5 8.7 7.8 6.3 7.6 8.1 8.4 
2 7.7 6.4 7.3 6.7 7.3 6.9 8.1 5.9 
2.0 8.5 7.8 9.2 9.7 7.7 9.4 8.4 8.7 
                  
1.0 8.6 6.4 7.3 7.4 7.5 6.5 8.7 6.4 
 
